<act><title>


    THE DRUGS AND COSMETICS ACT, 1940</title> 
 
 
 
  
 

  
 <article>
<number>1</number> 
    Short title, extent and commencement.—
<section><number>1</number> 
    This Act may be called the Drugs 

    1[and Cosmetics] Act, 
    1940.
 </section><section>
<number>2</number> It 
    extends to the whole of India 

    2[***].
 </section><section>
<number>3</number> It 
    shall come into force at once; but Chapter III shall take effect only from 
    such date3
    as the Central 
    Government may, by notification in the Official Gazette, appoint in this 
    behalf, and Chapter IV shall take effect in a particular State only from 
    such date3 as 
    the State Government may, by like notification, appoint in this behalf:
 


    4[Provided that in 
    relation to the State of Jammu and Kashmir, Chapter III shall take effect 
    only from such date5 after 
    the commencement of the Drugs and Cosmetics (Amendment) Act, 1972 (19 of 
    1972), as the Central Government may, by notification in the Official 
    Gazette, appoint in this behalf.] 
  










 



</section></article> 
 
 
 
  
 

  
 <article>
<number>2</number> 
    Application of other laws not barred.—The 
    provisions of this Act shall be in addition to, and not in derogation of, 
    the Dangerous Drugs Act, 1930 (2 of 1930), and any other law for the time 
    being in force.

 
  


</article> 

  
 <article><title><number>3</number> Definitions. </title>—In this Act, unless there is anything repugnant in the subject or context,— 
 
 <section><footcitenum>1</footcitenum>[<number>a</number> “ <footcitenum>2</footcitenum>[Ayurvedic, Siddha or Unani] drug” includes all medicines intended for internal or external use for or in the diagnosis, treatment, mitigation or prevention of <footcitenum>3</footcitenum>[disease or disorder in human beings or animals, and manufactured] exclusively in accordance with the formulae described in, the authoritative books of <footcitenum>4</footcitenum>[Ayurvedic, Siddha and Unani Tibb systems of medicine], specified in the First Schedule;] 
 </section><section><footcitenum>5</footcitenum>[<number>aa</number> “the Board” means— 
 
 <subsection><number>i</number> in relation to <footcitenum>2</footcitenum>[Ayurvedic, Siddha or Unani] drug, the <footcitenum>6</footcitenum>[Ayurvedic, Siddha and Unani Drugs Technical Advisory Board] constituted under section 33C; and 
 </subsection><subsection><number>ii</number> in relation to any other drug or cosmetic, the Drugs Technical Advisory Board constituted under section 5;] 
</subsection>
 <footcitenum>5</footcitenum>[ <footcitenum>7</footcitenum>[(aaa)] “cosmetic” means any article intended to be rubbed, poured, sprinkled or sprayed on, or introduced into, or otherwise applied to, the human body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering the appearance, and includes any article intended for use as a component of cosmetic <footcitenum>8</footcitenum>[***];] 
 </section><section><footcitenum>9</footcitenum>[<number>b</number> “drug” includes— 
 
 <subsection><footcitenum>10</footcitenum>[<number>i</number> all medicines for internal or external use of human beings or animals and all substances intended to be used for or in the diagnosis, treatment, mitigation or prevention of any disease or disorder in human beings or animals, including preparations applied on human body for the purpose of repelling insects like mosquitoes;] 
 </subsection><subsection><number>ii</number> such substances (other than food) intended to affect the structure or any function of the human body or intended to be used for the destruction of <footcitenum>11</footcitenum>[vermin] or insects which cause disease in human beings or animals, as may be specified from time to time by the Central Government by notification in the Official Gazette;] 
 </subsection><subsection><footcitenum>12</footcitenum>[<number>iii</number> all substances intended for use as components of a drug including empty gelatin capsules; and 
 </subsection><subsection><number>iv</number> such devices* intended for internal or external use in the diagnosis, treatment, mitigation or prevention of disease or disorder in human beings or animals, as may be specified from time to time by the Central Government by notification in the Official Gazette, after consultation with the Board;] 
</subsection>
 </section><section><footcitenum>13</footcitenum>[<number>c</number> “Government Analyst” means— 
 
 <subsection><number>i</number> in relation to <footcitenum>14</footcitenum>[Ayurvedic, Siddha or Unani] drug, a Government Analyst appointed by the Central Government or a State Government under section 33F; and 
 </subsection><subsection><number>ii</number> in relation to any other drug or cosmetic, a Government Analyst appointed by the Central Government or a State Government under section 20;] 
</subsection>
 <footcitenum>15</footcitenum>[***] 
 </section><section><footcitenum>16</footcitenum>[<number>e</number> “Inspector” means— 
 
 <subsection><number>i</number> in relation to <footcitenum>14</footcitenum>[Ayurvedic, Siddha or Unani] drug, an Inspector appointed by the Central Government or a State Government under section 33G; and 
 </subsection><subsection><number>ii</number> in relation to any other drug or cosmetic, an Inspector appointed by the Central Government or a State Government under section 21;] 
</subsection>
 </section><section><footcitenum>17</footcitenum>[<number>f</number> “manufacture” in relation to any drug <footcitenum>18</footcitenum>[or cosmetic] includes any process or part of a process for making, altering, ornamenting, finishing, packing, labelling, breaking up or otherwise treating or adopting any drug <footcitenum>13</footcitenum>[or cosmetic] with a view to its <footcitenum>19</footcitenum>[sale or distribution] but does not include the compounding or dispensing <footcitenum>20</footcitenum>[of any drug, or the packing of any drug or cosmetic,] in the ordinary course of retail business; and “to manufacture” shall be construed accordingly;] 
 </section><section><footcitenum>21</footcitenum>[<number>g</number>] “to import”, with its grammatical variations and cognate expressions means to bring into <footcitenum>22</footcitenum>[ India ]; 
 </section><section><footcitenum>23</footcitenum>[<number>h</number> “patent or proprietary medicine” means,— 
 
 
 </section><section><number>i</number> in relation to Ayurvedic, Siddha or Unani Tibb systems of medicine all formulations containing only such ingredients mentioned in the formulae described in the authoritative books of Ayurveda, Siddha or Unani Tibb systems of medicine specified in the First Schedule, but does not include a medicine which is administered by parenteral route and also a formulation included in the authoritative books as specified in clause (a); 
 <subsection><number>ii</number> in relation to any other systems of medicine, a drug which is a remedy or prescription presented in a form ready for internal or external administration of human beings or animals and which is not included in the edition of the Indian Pharmacopoeia for the time being or any other Pharmacopoeia authorised in this behalf by the Central Government after consultation with the Drugs Technical Advisory Board constituted under section 5;] 
</subsection></section><section><footcitenum>24</footcitenum>[<number>i</number> “prescribed” means prescribed by rules made under this Act.] 
 <footcitenum>25</footcitenum>[***] 
</section>



















 
 * The Central Government has specified ( vide S.O. 1468(E), dated 6th October, 2005) the following devices intended for external or internal use in human beings or drugs with immediate effect, namely:— 
 
 <section><number>i</number> Cardiac Stents (vi) Bone Cements 
 </section><section><number>ii</number> Drug Eluding Stents (vii) Heart Valves 
 </section><section><number>iii</number> Catheters (viii) Sclap Vein Set 
 </section><section><number>iv</number> Intra Ocular Lenses (ix) Orthopaedic Implants 
 </section><section><number>v</number> I.V. Cannulac (x) Internal Prosthetic Replacements. 
</section>














</article> 
 
 
 
  
 

  
 <article>


    1[<number>3A</number> Construction 
    of references to any law not in force or any functionary not in existence in 
    the State of Jammu and Kashmir.—Any reference in this Act to any law 
    which is not in force, or any functionary not in existence, in the State of 
    Jammu and Kashmir, shall, in relation to that State, be construed as a 
    reference to the corresponding law in force, or to the corresponding 
    functionary in existence, in that State.] 6[3A. 
    Construction of references to any law not in force or any functionary not in 
    existence in the State of Jammu and Kashmir.—Any reference in this Act 
    to any law which is not in force, or any functionary not in existence, in 
    the State of Jammu and Kashmir, shall, in relation to that State, be 
    construed as a reference to the corresponding law in force, or to the 
    corresponding functionary in existence, in that State.]" 
  




 



</article> 
 
 
 
  
 

  
 <article>
<number>4</number> 
    Presumption as to poisonous substances.—Any 
    substance specified as poisonous by rule made under Chapter III or Chapter 
    IV 

    1[or Chapter IVA] 
    shall be deemed to be a poisonous substance for the purpose of Chapter III 
    or Chapter IV 

    1[or Chapter IVA], as 
    the case may be. —Any 
    substance specified as poisonous by rule made under Chapter III or Chapter 
    IV 

    1[or Chapter IVA] 
    shall be deemed to be a poisonous substance for the purpose of Chapter III 
    or Chapter IV 

    1[or Chapter IVA], as 
    the case may be." 
  




 



</article> 
 
 
 
  
 

  
 <article>
<number>5</number> 
    The Drugs Technical Advisory Board.—
<section><number>1</number> 
    The Central Government shall, as soon as may be, constitute a Board (to be 
    called the Drugs Technical Advisory Board) to advise the Central Government 
    and the State Governments on technical matters arising out of the 
    administration of this Act and to carry out the other functions assigned to 
    it by this Act.
 


    1[(2) The Board shall 
    consist of the following members, namely:— 
 <subsection>
<number>i</number>    the Director General of Health 
    Services, ex officio, who shall be Chairman;
 </subsection><subsection>
<number>ii</number>    the Drugs Controller, India, ex 
    officio;
 </subsection><subsection>
<number>iii</number>    the Director of the Central Drugs 
    Laboratory, Calcutta, ex officio;
 </subsection><subsection>
<number>iv</number>    the Director of the Central Research 
    Institute, Kasauli, ex officio;
 </subsection><subsection>
<number>v</number>    the Director of the Indian Veterinary 
    Research Institute, Izatnagar, ex officio;
 </subsection><subsection>
<number>vi</number>    the President of the Medical Council 
    of India, ex officio;
 </subsection><subsection>
<number>vii</number>    the President of the Pharmacy Council 
    of India, ex officio;
 </subsection><subsection>
<number>viii</number>    the Director of the Central Drug 
    Research Institute, Lucknow, ex officio;
 </subsection><subsection>
<number>ix</number>    two persons to be nominated by the 
    Central Government from among persons who are in charge of drugs control in 
    the States;
 </subsection><subsection>
<number>x</number>    one person, to be elected by the 
    Executive Committee of the Pharmacy Council of India, from among teachers in 
    pharmacy or pharmaceutical chemistry or pharmacognosy on the staff of an 
    Indian University or a college affiliated thereto;
 </subsection><subsection>
<number>xi</number>    one person, to be elected by the 
    Executive Committee of the Medical Council of India, from among teachers in 
    medicine or therapeutics on the staff of an Indian University or a college 
    affiliated thereto;
 <subsubsection>
<number>xii</number>    one person to be nominated by the 
    Central Government from the pharmaceutical industry;
 </subsubsection><subsubsection>
<number>xiii</number>    one pharmacologist to be elected by 
    the Governing Body of the Indian Council of Medical Research;
 </subsubsection><subsubsection>
<number>xiv</number>    one person to be elected by the 
    Central Council of the Indian Medical Association;
 </subsubsection><subsubsection>
<number>xv</number>    one person to be elected by the 
    Council of the Indian Pharmaceutical Association;
 </subsubsection><subsubsection>
<number>xvi</number>    two persons holding the appointment 
    of Government Analyst under this Act, to be nominated by the Central 
    Government.]
 </subsubsection></subsection></section><section>
<number>3</number> The 
    nominated and elected members of the Board shall hold office for three 
    years, but shall be eligible for re-nomination and re-election:
 
<footcitenum>29</footcitenum>[Provided 
    that the person nominated or elected, as the case may be, under clause (ix) 
    or clause (x) or clause (xi) or clause (xvi) of sub-section (2) shall hold 
    office for so long as he holds the appointment of the office by virtue of 
    which he was nominated or elected to the Board.]
 </section><section>
<number>4</number> The 
    Board may, subject to the previous approval of the Central Government, make 
    bye-laws fixing a quorum and regulating its own procedure and the conduct of 
    all business to be transacted by it.
 </section><section>
<number>5</number> The 
    Board may constitute sub-committees and may appoint to such sub-committees 
    for such periods, not exceeding three years, as it may decide, or 
    temporarily for the consideration of particular matters, persons who are not 
    members of the Board.
 </section><section>
<number>6</number> The 
    functions of the Board may be exercised notwithstanding any vacancy therein.
 </section><section>
<number>7</number> The 
    Central Government shall appoint a person to be Secretary of the Board and 
    shall provide the Board with such clerical and other staff as the Central 
    Government considers necessary.
  





 



</section></article> 
 
 
 
  
 

  
 <article>
<number>6</number> 
    The Central Drugs Laboratory.—
<section><number>1</number> 
    The Central Government shall, as soon as may be, establish a Central Drugs 
    Laboratory under the control of a Director to be appointed by the Central 
    Government, to carry out the functions entrusted to it by this Act or any 
    rules made under this Chapter:
 
Provided 
    that, if the Central Government so prescribes, the functions of the Central 
    Drugs Laboratory in respect of any drug or class of drugs 

    1[or cosmetic or class 
    of cosmetics] shall be carried out at the Central Research Institute, 
    Kasauli, or at any other prescribed Laboratory and the functions of the 
    Director of the Central Drugs Laboratory in respect of such drug or class of 
    drugs 

    1[or such cosmetic or 
    class of cosmetics] shall be exercised by the Director of that Institute or 
    of that other Laboratory, as the case may be.
 </section><section>
<number>2</number> The 
    Central Government may, after consultation with the Board, make rules 
    prescribing—
 <subsection>
<number>a</number>    the functions of the Central Drugs 
    Laboratory;
 
<footcitenum>31</footcitenum>[***] 
 </subsection><subsection>
<number>d</number>    the procedure for the submission 
    of the said Laboratory 
3[under 
    Chapter IV or Chapter IVA] of samples of drugs <footcitenum>31</footcitenum>[or cosmetics] 
    for analysis or test, the forms of the Laboratory’s reports thereon and the 
    fees payable in respect of such reports;
 </subsection><subsection>
<number>e</number>    such other matters as may be necessary 
    or expedient to enable the said Laboratory to carry out its functions;
 </subsection><subsection>
<number>f</number>    the matters necessary to be prescribed 
    for the purposes of the proviso to sub-section (1).
  






 



</subsection></section></article> 
 
 
 
  
 

  
 <article>
<number>7</number> 
    The Drugs Consultative Committee.—
<section><number>1</number> 
    The Central Government may constitute an advisory committee to be called 
    “the Drugs Consultative Committee” to advise the Central Government, the 
    State Governments and the Drugs Technical Advisory Board on any matter 
    tending to secure uniformity throughout 

    1[India] in the 
    administration of this Act.
 </section><section>
<number>2</number> The 
    Drugs Consultative Committee shall consist of two representatives of the 
    Central Government to be nominated by that Government and one representative 
    of each State Government to be nominated by the State Government concerned.
 </section><section>
<number>3</number> The Drugs 
    Consultative Committee shall meet when required to do so by the Central 
    Government and shall have power to regulate its own procedure.
  




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>7A</number> Sections 5 
    and 7 not to apply to Ayurvedic, Siddha or Unani drugs.—Nothing 
    contained in sections 5 and 7 shall apply to 

    2[Ayurvedic, Siddha or 
    Unani] drugs.] 
  





 



</article> 
 
 
 
  
 

  
 <article>
<number>8</number> 
    Standards of quality.—1[
<section><number>1</number> 
    For the purposes of this Chapter, the expression “standard quality” means—
 <subsection>
<number>a</number>    in relation to a drug, that the 
    drug complies with the standard set out in 
2[the 
    Second Schedule], and
 </subsection><subsection>
<number>b</number>    in relation to a cosmetic, that the 
    cosmetic complies with such standard as may be prescribed.]
 </subsection></section><section>
<number>2</number> The 
    Central Government, after consultation with the Board and after giving by 
    notification in the Official Gazette not less than three months’ notice of 
    its intention so to do, may by a like notification add to or otherwise amend
    

    2[the Second 
    Schedule], for the purposes of this Chapter, and thereupon 

    2[the Second Schedule] 
    shall be deemed to be amended accordingly.
  





 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>9</number> Misbranded 
    drugs.—For the purposes of this Chapter, a drug shall be deemed to be 
    misbranded,— 
 <section>
<number>a</number>    if it is so coloured, coated, powdered 
    or polished that damage is concealed or if it is made to appear of better or 
    greater therapeutic value than it really is; or
 </section><section>
<number>b</number>    if it is not labelled in the prescribed 
    manner; or
 </section><section>
<number>c</number>    if its label or container or anything 
    accompanying the drug bears any statement, design or device which makes any 
    false claim for the drug or which is false or misleading in any particular.]
 





 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>9A</number> Adulterated 
    drugs.—For the purposes of this Chapter, a drug shall be deemed to be 
    adulterated,—
 <section>
<number>a</number>    if it consists, in whole or in part, of 
    any filthy, putrid or decomposed substance; or
 </section><section>
<number>b</number>    if it has been prepared, packed or 
    stored under insanitary conditions whereby it may have been contaminated 
    with filth or whereby it may have been rendered injurious to health; or
 </section><section>
<number>c</number>    if its container is composed in whole 
    or in part, of any poisonous or deleterious substance which may render the 
    contents injurious to health; or
 </section><section>
<number>d</number>    if it bears or contains, for purposes 
    of colouring only, a colour other than one which is prescribed; or
 </section><section>
<number>e</number>    if it contains any harmful or toxic 
    substance which may render it injurious to health; or
 </section><section>
<number>f</number>    if any substance has been mixed 
    therewith so as to reduce its quality or strength.]
  




 



</section></article> 
 
 
 
  
 

  
 <article>
<footcitenum>40</footcitenum>[<number>9B</number> 
    Spurious drugs.—For 
    the purposes of this Chapter, a drug shall be deemed to be spurious,—
 <section>
<number>a</number>    if it is imported under a name which 
    belongs to another drug; or
 </section><section>
<number>b</number>    if it is an imitation of, or is a 
    substitute for, another drug or resembles another drug in a manner likely to 
    deceive or bears upon it or upon its label or container the name of another 
    drug unless it is plainly and conspicuously marked so as to reveal its true 
    character and its lack of identity with such other drug; or
 </section><section>
<number>c</number>    if the label or container bears the 
    name of an individual or company purporting to be the manufacturer of the 
    drug, which individual or company is fictitious or does not exist; or
 </section><section>
<number>d</number>    if it has been substituted wholly or in 
    part by another drug or substance; or
 </section><section>
<number>e</number>    if it purports to be the product of a 
    manufacturer of whom it is not truly a product.]
  




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>9C</number> Misbranded 
    cosmetics.—For 
    the purposes of this Chapter, a cosmetic shall be deemed to be misbranded— 
 <section>
<number>a</number>    if it contains a colour which is not 
    prescribed; or
 </section><section>
<number>b</number>    if it is not labelled in the prescribed 
    manner; or
 </section><section>
<number>c</number>    if the label or container or anything 
    accompanying the cosmetic bears any statement which is false or misleading 
    in any particular.]
  




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>9D</number> Spurious 
    cosmetics.—For 
    the purposes of this Chapter, a cosmetic shall be deemed to be spurious,— 
 <section>
<number>a</number>    if it is imported under a name which 
    belongs to another cosmetic; or
 </section><section>
<number>b</number>    if it is an imitation of, or is a 
    substitute for, another cosmetic or resembles another cosmetic in a manner 
    likely to deceive or bears upon it or upon its label or container the name 
    of another cosmetic, unless it is plainly and conspicuously marked so as to 
    reveal its true character and its lack of identity with such other cosmetic; 
    or
 </section><section>
<number>c</number>    if the label or container bears the 
    name of an individual or a company purporting to be the manufacturer of the 
    cosmetic which individual or company is fictitious or does not exist; or
 </section><section>
<number>d</number>    if it purports to be the product of a 
    manufacturer of whom it is not truly a product.]
  




 



</section></article> 
 
 
 
  
 

  
 <article>
<number>10</number> 
    Prohibition of import of certain drugs or cosmetics.—From 
    such date1 as 
    may be fixed by the Central Government by notification in the Official 
    Gazette in this behalf, no person shall import—
 <section>
<number>a</number>    any drug 
2[or 
    cosmetic] which is not of standard quality;
 

3[(b) 
       any misbranded drug 
4[or 
    misbranded or spurious cosmetic];]
 

5[(bb)    
    any 6[adulterated 
    or spurious] drug;]
 </section><section>
<number>c</number>    any drug 
2[or 
    cosmetic] for the import of which a licence is prescribed, otherwise than 
    under, and in accordance with, such licence;
 

7[(d) 
       any patent or proprietary medicine, unless there is displayed in the 
    prescribed manner on the label or container thereof 
8[the 
    true formula or list of active ingredients contained in it together with the 
    quantities thereof];]
 </section><section>
<number>e</number>    any drug which by means of any 
    statement, design or device accompanying it or by any other means, purports 
    or claims to cure or mitigate any such disease or ailment, or to have any 
    such other effect, as may be prescribed;
 

9[(ee) 
       any cosmetic containing any ingredient which may render it unsafe or 
    harmful or use under the directions indicated or recommended;]
 </section><section>
<number>f</number>    any drug 
1[or 
    cosmetic] the import of which is prohibited by rule made under this Chapter:
 
Provided 
    that nothing in this section shall apply to the import, subject to 
    prescribed conditions, of small quantities of any drug for the purpose of 
    examination, test or analysis or for personal use:
 
Provided 
    further that the Central Government may, after consultation with the Board, 
    by notification in the Official Gazette, permit, subject to any conditions 
    specified in the notification, the import of any drug or class of drugs not 
    being of standard quality.
 


    10[***]
 

 
 

 

 

 

 

 

 

 

 

 




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>10A</number> Power of 
    Central Government to prohibit import of drugs and cosmetics in public 
    interest.—Without prejudice to any other provision contained in this 
    Chapter, if the Central Government is satisfied that the use of any drug or 
    cosmetic is likely to involve any risk to human beings or animals or that 
    any drug does not have the therapeutic value claimed for it or contains 
    ingredients and in such quantity for which there is no therapeutic 
    justification and that in the public interest it is necessary or expedient 
    so to do then, that Government may, by notification in the Official Gazette, 
    prohibit the import of such drug or cosmetic.] 
 




 



</article> 
 
 
 
  
 

  
 <article>
<number>11</number> 
    Application of law relating to sea customs and powers of Customs Officers.—
<section><number>1</number> 
    The law for the time being in force relating to sea customs and to goods, 
    the import of which is prohibited by section 18 of the Sea Customs Act, 1878 
    (8 of 1878)1 shall, 
    subject to the provisions of section 13 of this Act, apply in respect of 
    drugs 

    2[and cosmetics] the 
    import of which is prohibited under this Chapter, and officers of Customs 
    and officers empowered under that Act to perform the duties imposed thereby 
    on a 

    3[Commissioner of 
    Customs] and other officers of Customs, shall have the same powers in 
    respect of such drugs 

    4[and cosmetics] as 
    they have for the time being in respect of such goods as aforesaid.
 


    5[(2) Without 
    prejudice to the provisions of sub-section (1), the 

    6[Commissioner of 
    Customs] or any officer of the Government authorised by the Central 
    Government in this behalf, may detain any imported package which he suspects 
    to contain any drug 

    7[or cosmetic] the 
    import of which is prohibited under this Chapter and shall forthwith report 
    such detention to the Drugs Controller, India, and if necessary, forward the 
    package or sample of any suspected drug 

    7[or cosmetic] found 
    therein to the Central Drugs Laboratory.] 
 










 



</section></article> 
 
 
 
  
 

  
 <article>
<number>12</number> 
    Power of Central Government to make rules.—
<section><number>1</number> 
    The Central Government may, 

    1[after consultation 
    with or on the recommendation of the Board] and after previous publication 
    by notification in the Official Gazette, make rules for the purpose of 
    giving effect to the provisions of this Chapter: —(1) 
    The Central Government may, 

    4[after consultation 
    with or on the recommendation of the Board] and after previous publication 
    by notification in the Official Gazette, make rules for the purpose of 
    giving effect to the provisions of this Chapter\:" 
 


    2[Provided that 
    consultation with the Board may be dispensed with if the Central Government 
    is of opinion that circumstances have arisen which render it necessary to 
    make rules without such consultation, but in such a case the Board shall be 
    consulted within six months of the making of the rules and the Central 
    Government shall take into consideration any suggestions which the Board may 
    make in relation to the amendment of the said rules.] 5[Provided 
    that consultation with the Board may be dispensed with if the Central 
    Government is of opinion that circumstances have arisen which render it 
    necessary to make rules without such consultation, but in such a case the 
    Board shall be consulted within six months of the making of the rules and 
    the Central Government shall take into consideration any suggestions which 
    the Board may make in relation to the amendment of the said rules.]" 
 </section><section>
<number>2</number> 
    Without prejudice to the generality of the foregoing power, such rules may—
 <subsection>
<number>a</number>    specify the drugs or classes of 
    drugs 
    3[or cosmetics or classes of cosmetics] for the import 
    of which a licence is required, 
4[and 
    prescribe the form and conditions of such licences, the authority empowered 
    to issue the same, the fees payable therefor and provide for the 
    cancellation, or suspension of such licence in any case where any provision 
    of this Chapter or the rules made thereunder is contravened or any of the 
    conditions subject to which the licence is issued is not complied with];
 </subsection><subsection>
<number>b</number>    prescribe the methods of test or 
    analysis to be employed in determining whether a drug 
3[or 
    cosmetic] is of standard quality;
 </subsection><subsection>
<number>c</number>    prescribe, in respect of biological and 
    organometallic compounds, the units or methods of standardisation;
 

5[(cc)    
    prescribe under clause (d) of 
6[section 
    9A] the colour or colours which a drug may bear or contain for purposes of 
    colouring;]  
    1[(cc) prescribe under clause (d) of 
2[section 
    9A] the colour or colours which a drug may bear or contain for purposes of 
    colouring;]" 
 </subsection><subsection>
<number>d</number>    specify the diseases or ailments 
    which an imported drug may not purport or claim 
7[to 
    prevent, cure or mitigate] and such other effects which such drug may not 
    purport or claim to have;
 </subsection><subsection>
<number>e</number>    prescribe the conditions subject to 
    which small quantities of drugs, the import of which is otherwise prohibited 
    under this Chapter, may be imported for the purpose of examination, test or 
    analysis or for personal use;
 </subsection><subsection>
<number>f</number>    prescribe the places at which 
    drugs 
    8[or cosmetics] may be imported, and prohibit their 
    import at any other place;
 </subsection><subsection>
<number>g</number>    require the date of manufacture and the 
    date of expiry of potency to be clearly and truly stated on the label or 
    container of any specified imported drug or class of such drug, and prohibit 
    the import of the said drug or class of drug after the expiry of a specified 
    period from the date of manufacture;
 </subsection><subsection>
<number>h</number>    regulate the submission by 
    importers, and the securing, of samples of drugs 
8[or 
    cosmetics] for examination, test or analysis by the Central Drugs 
    Laboratory, and prescribe the fees, if any, payable for such examination, 
    test or analysis;
 </subsection><subsection>
<number>i</number>    prescribe the evidence to be 
    supplied, whether by accompanying documents or otherwise, of the quality of 
    drugs 
    8[or cosmetics] sought to be imported, the procedure 
    of officers of Customs in dealing with such evidence, and the manner of 
    storage at places of import of drugs 
8[or 
    cosmetics] detained pending admission;
 </subsection><subsection>
<number>j</number>    provide for the exemption, 
    conditionally or otherwise, from all or any of the provisions of this 
    Chapter and the rules made thereunder of drugs 
8[or 
    cosmetics] imported for the purpose only of transport through, and export 
    from, 
    9[India];
 </subsection><subsection>
<number>k</number>    prescribe the conditions to be 
    observed in the packing in bottles, packages or other containers, of 
    imported drugs 
8[or 
    cosmetics] 
10[including 
    the use of packing material which comes into direct contact with the drugs];
 </subsection><subsection>
<number>l</number>    regulate the mode of labelling 
    drugs 
    8[or cosmetics] imported for sale in packages, and 
    prescribe the matters which shall or shall not be included in such labels;
 </subsection><subsection>
<number>m</number>    prescribe the maximum proportion of any 
    poisonous substance which may be added to or contained in any imported drug, 
    prohibit the import of any drug in which that proportion is exceeded, and 
    specify substances which shall be deemed to be poisonous for the purposes of 
    this Chapter and the rules made thereunder;
 </subsection><subsection>
<number>n</number>    require that the accepted scientific 
    name of any specified drug shall be displayed in the prescribed manner on 
    the label or wrapper of any imported, patent or proprietary medicine 
    containing such drug;
 </subsection><subsection>
<number>o</number>    provide for the exemption, 
    conditionally or otherwise, from all or any of the provisions of this 
    Chapter or the rules made thereunder of any specified drug or class of drugs
    11[or 
    cosmetics or class of cosmetics].
 
 














 



</subsection></section></article> 
 
 
 
  
 

  
 <article>


    1[<number>13</number> Offences.—
<section><number>1</number> 
    Whoever himself or by any other person on his behalf imports,— 2[13. 
    Offences.—(1) Whoever himself or by any other person on his behalf 
    imports,—" 
 <subsection>
<number>a</number>    any drug deemed to be adulterated under 
    section 9A or deemed to be a spurious drug under section 9B or any spurious 
    cosmetic referred to in section 9D or any cosmetic of the nature referred to 
    in clause (ee) of section 10 shall be punishable with imprisonment for a 
    term which may extend to three years and a fine which may extend to five 
    thousand rupees;
 </subsection><subsection>
<number>b</number>    any drug or cosmetic other than a drug 
    or cosmetic referred to in clause (a), the import of which is prohibited 
    under section 10, or any rule made under this Chapter, shall be punishable 
    with imprisonment for a term which may extend to six months, or with fine 
    which may extend to five hundred rupees, or with both;
 </subsection><subsection>
<number>c</number>    any drug or cosmetic in contravention 
    of the provisions of any notification issued under section 10A, shall be 
    punishable with imprisonment for a term which may extend to three years, or 
    with fine which may extend to five thousand rupees, or with both.
 </subsection></section><section>
<number>2</number> 
    Whoever having been convicted of an offence—
 <subsection>
<number>a</number>    under clause (a) or clause (c) of 
    sub-section (1), is again convicted of an offence under that clause, shall 
    be punishable with imprisonment for a term which may extend to five years, 
    or with fine which may extend to ten thousand rupees, or with both;
 </subsection><subsection>
<number>b</number>    under clause (b) of sub-section (1), is 
    again convicted of an offence under that clause, shall be punishable with 
    imprisonment for a term which may extend to one year, or with fine which may 
    extend to one thousand rupees, or with both.
 </subsection></section><section>
<number>3</number> The 
    punishment provided by this section shall be in addition to any penalty to 
    which the offender may be liable under the provisions of section 11.]
 




 



</section></article> 
 
 
 
  
 

  
 <article>
<number>14</number> 
    Confiscation.—Where 
    any offence punishable under section 13 has been committed, the consignment 
    of the drugs 

    1[or cosmetics] in 
    respect of which the offence has been committed shall be liable to 
    confiscation.
 
 




 



</article> 
 
 
 
  
 

  
 <article>
<number>15</number> 
    Jurisdiction.—No 
    Court inferior to that 

    1[of a Metropolitan 
    Magistrate or of a Judicial Magistrate of the first class] shall try an 
    offence punishable under
    section 13.
 
 




 



</article> 
 
 
 
  
 

  
 <article>
<number>16</number> 
    Standards of quality.—
    

    1[
<section><number>1</number> For the purposes 
    of this Chapter, the expression “standard quality” means—
 <subsection>
<number>a</number>    in relation to a drug, that the 
    drug complies with the standard set out in 
2[the 
    Second Schedule], and
 </subsection><subsection>
<number>b</number>    in relation to a cosmetic, that the 
    cosmetic complies with such standard as may be prescribed.]
 </subsection></section><section>
<number>2</number> The
    

    3[Central Government], 
    after consultation with the Board and after giving by notification in the 
    Official Gazette not less than three months’ notice of its intention so to 
    do, may by a like notification add to or otherwise amend 

    2[the Second Schedule] 
    for the purposes of this Chapter, and thereupon 

    2[the Second Schedule] 
    shall be deemed to be amended accordingly.
 






 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>17</number> Misbranded 
    drugs.—For the purposes of this Chapter, a drug shall be deemed to be 
    misbranded,—
 <section>
<number>a</number>    if it is so coloured, coated, powdered 
    or polished that damage is concealed or if it is made to appear of better or 
    greater therapeutic value than it really is; or
 </section><section>
<number>b</number>    if it is not labelled in the prescribed 
    manner; or
 </section><section>
<number>c</number>    if its label or container or anything 
    accompanying the drug bears any statement, design or device which makes any 
    false claim for the drug or which is false or misleading in any particular.]
 
 




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>17A</number> Adulterated 
    drugs.—For 
    the purposes of this Chapter, a drug shall be deemed to be adulterated,—
 <section>
<number>a</number>    if it consists in whole or in part, of 
    any filthy, putrid or decomposed substance; or
 </section><section>
<number>b</number>    if it has been prepared, packed or 
    stored under insanitary conditions whereby it may have been contaminated 
    with filth or whereby it may have been rendered injurious to health; or
 </section><section>
<number>c</number>    if its container is composed, in whole 
    or in part, of any poisonous or deleterious substance which may render the 
    contents injurious to health; or
 </section><section>
<number>d</number>    if it bears or contains, for purposes 
    of colouring only, a colour other than one which is prescribed; or
 </section><section>
<number>e</number>    if it contains any harmful or toxic 
    substance which may render it injurious to health; or
 </section><section>
<number>f</number>    if any substance has been mixed 
    therewith so as to reduce its quality or strength.]
 



 







 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>17B</number> Spurious drugs.—For 
    the purposes of this Chapter, a drug shall be deemed to be spurious,— 
 <section>
<number>a</number>    if it is manufactured under a name 
    which belongs to another drug; or
 </section><section>
<number>b</number>    if it is an imitation of, or is a 
    substitute for, another drug or resembles another drug in a manner likely to 
    deceive or bears upon it or upon its label or container the name of another 
    drug unless it is plainly and conspicuously marked so as to reveal its true 
    character and its lack of identity with such other drug; or
 </section><section>
<number>c</number>    if the label or container bears the 
    name of an individual or company purporting to be the manufacturer of the 
    drug, which individual or company is fictitious or does not exist; or
 </section><section>
<number>d</number>    if it has been substituted wholly or in 
    part by another drug or substance; or 
 </section><section>
<number>e</number>    if it purports to be the product of a 
    manufacturer of whom it is not truly a product.]
 
 




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>17C</number> Misbranded 
    cosmetics.—For 
    the purposes of this Chapter, a cosmetic shall be deemed to be misbranded,— —For 
    the purposes of this Chapter, a cosmetic shall be deemed to be misbranded,—" 
 <section>
<number>a</number>    if it contains a colour which is not 
    prescribed; or
 </section><section>
<number>b</number>    if it is not labelled in the prescribed 
    manner; or
 </section><section>
<number>c</number>    if the label or container or anything 
    accompanying the cosmetic bears any statement which is false or misleading 
    in any particular.]
 
 




 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>17D</number> Spurious 
    cosmetics.—For 
    the purposes of this Chapter, a cosmetic shall be deemed to be spurious,— —For 
    the purposes of this Chapter, a cosmetic shall be deemed to be spurious,—" 
 <section>
<number>a</number>    if it is manufactured under a name 
    which belongs to another cosmetic; or
 </section><section>
<number>b</number>    if it is an imitation of, or a 
    substitute for, another cosmetic or resembles another cosmetic in a manner 
    likely to deceive or bears upon it or upon its label or container the name 
    of another cosmetic unless it is plainly and conspicuously marked so as to 
    reveal its true character and its lack of identity with such other cosmetic; 
    or
 </section><section>
<number>c</number>    if the label or container bears the 
    name of an individual or a company purporting to be the manufacturer of the 
    cosmetic which individual or company is fictitious or does not exist; or
 </section><section>
<number>d</number>    if it purports to be the product of a 
    manufacturer of whom it is not truly a product.]
 
 




 



</section></article> 

  
 <article><title><footcitenum>73</footcitenum>[<number>17E</number> Adulterated cosmetics. </title>—For the purposes 
of this Chapter, a cosmetic shall be deemed to be adulterated,— 
 
 <section><number>a</number> if it consists in whole or in part, of any filthy, putrid or decomposed 
  substance; or 
 </section><section><number>b</number> if it has been prepared, packed or stored under insanitary conditions 
  whereby it may have been contaminated with filth or whereby it may have been 
  rendered injurious to health; or 
 </section><section><number>c</number> if its container is composed, in whole or in part, of any poisonous or 
  deleterious substance which may render the contents injurious to health; or 
  
 </section><section><number>d</number> if it bears or contains, for purposes of colouring only, a colour other 
  than one which is prescribed; or 
 </section><section><number>e</number> if it contains any harmful or toxic substance which may render it 
  injurious to health; or 
 </section><section><number>f</number> if any substance has been mixed therewith so as to reduce its quality 
  or strength.] </section>

</article> 

  
 <article><title><number>18</number> Prohibition of manufacture and sale of certain drugs and cosmetics. </title>—From such date<footcitenum>74</footcitenum> as may be fixed by the State Government by notification in the Official Gazette in this behalf, no person shall himself or by any other person on his behalf— 
 
 <section><number>a</number> <footcitenum>75</footcitenum>[manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale,] or distribute— 
 
 <subsection><footcitenum>76</footcitenum>[<number>i</number> any drug which is not of a standard quality, or is misbranded, adulterated or spurious; 
 </subsection><subsection><footcitenum>77</footcitenum>[<number>ii</number> any cosmetic which is not of a standard quality, or is misbranded, adulterated or spurious;]] 
 </subsection><subsection><footcitenum>78</footcitenum>[<number>iii</number> any patent or proprietary medicine, unless there is displayed in the prescribed manner on the label or container thereof <footcitenum>79</footcitenum>[the true formula or list of active ingredients contained in it together with the quantities, thereof];] 
 </subsection><subsection><number>iv</number> any drug which by means of any statement design or device accompanying it or by any other means, purports or claims <footcitenum>80</footcitenum>[to prevent, cure or mitigate] any such disease or ailment, or to have any such other effect as may be prescribed; 
 </subsection><subsection><footcitenum>81</footcitenum>[<number>v</number> any cosmetic containing any ingredient which may render it unsafe or harmful for use under the directions indicated or recommended; 
 </subsection><subsection><number>vi</number> any drug or cosmetic in contravention of any of the provisions of this Chapter or any rule made thereunder;] 
</subsection>
 </section><section><number>b</number> <footcitenum>82</footcitenum>[sell, or stock or exhibit or offer for sale,] or distribute any drug <footcitenum>83</footcitenum>[or cosmetic] which has been imported or manufactured in contravention of any of the provisions of this Act or any rule made thereunder; 
 </section><section><number>c</number> <footcitenum>84</footcitenum>[manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale,] or distribute any drug <footcitenum>83</footcitenum>[or cosmetic], except under, and in accordance with the conditions of, a licence issued for such purpose under this Chapter: 
 Provided that nothing in this section shall apply to the manufacture, subject to prescribed conditions, of small quantities of any drug for the purpose of examination, test or analysis: 
 Provided further that the <footcitenum>85</footcitenum>[Central Government] may, after consultation with the Board, by notification in the Official Gazette, permit, subject to any conditions specified in the notification, the <footcitenum>86</footcitenum>[manufacture for sale or for distribution, sale, stocking or exhibiting or offering for sale] or distribution of any drug or class of drugs not being of standard quality. 
 <footcitenum>87</footcitenum>[***] 
</section>









 
 “(ii) any cosmetic which is not of a standard quality or is misbranded or spurious;”. 











</article> 
 
 
 
  
 

  
 <article>


    1[<number>18A</number> Disclosure 
    of the name of the manufacturer, etc.—Every person, not being the 
    manufacturer of a drug or cosmetic or his agent for the distribution 
    thereof, shall, if so required, disclose to the Inspector the name, address 
    and other particulars of the person from whom he acquired the drug or 
    cosmetic.] 
 




 



</article> 
 
 
 
  
 

  
 <article>


    1[<number>18B</number> Maintenance 
    of records and furnishing of information.—Every person holding a licence 
    under clause (c) of section 18 shall keep and maintain such records, 
    registers and other documents as may be prescribed and shall furnish to any 
    officer or authority exercising any power or discharging any function under 
    this Act such information as is required by such officer or authority for 
    carrying out the purposes of this Act.] 
 
 




 



</article> 
 
 
 
  
 

  
 <article>
<number>19</number> 
    Pleas.—
<section><number>1</number> 
    Save as hereinafter provided in this section, it shall be no defence in a 
    prosecution under this Chapter to prove merely that the accused was ignorant 
    of the nature, substance or quality of the drug 

    1[or cosmetic] in 
    respect of which the offence has been committed or of the circumstances of 
    its manufacture or import, or that a purchaser, having bought only for the 
    purpose of test or analysis, has not been prejudiced by the sale.
 </section><section>
<number>2</number>
    

    2[For the purposes of 
    section 18 a drug shall not be deemed to be misbranded or 

    3[adulterated or 
    spurious] or to be below standard quality nor shall a cosmetic be deemed to 
    be misbranded or to be below standard quality] only by reason of the fact 
    that—
 <subsection>
<number>a</number>    there has been added thereto some 
    innocuous substance or ingredient because the same is required for the 
    manufacture or preparation of the drug 
4[or 
    cosmetic] as an article of commerce in a state fit for carriage or 
    consumption, and not to increase the bulk, weight or measure of the drug
    4[or 
    cosmetic] or to conceal its inferior quality or other defects; or
 

5[***] 
 </subsection><subsection>
<number>b</number>    in the process of manufacture, 
    preparation or conveyance some extraneous substance has unavoidably become 
    intermixed with it: provided that this clause shall not apply in relation to 
    any sale or distribution of the drug 
4[or 
    cosmetic] occurring after the vendor or distributor became aware of such 
    intermixture.
 


    6[(3) A person, not 
    being the manufacturer of a drug or cosmetic or his agent for the 
    distribution thereof, shall not be liable for a contravention of section 18 
    if he proves— 5[(3) 
    A person, not being the manufacturer of a drug or cosmetic or his agent for 
    the distribution thereof, shall not be liable for a contravention of section 
    18 if he proves—" 
 </subsection><subsection>
<number>a</number>    that he acquired the drug or cosmetic 
    from a duly licensed manufacturer, distributor or dealer thereof;
 </subsection><subsection>
<number>b</number>    that he did not know and could not, 
    with reasonable diligence, have ascertained that the drug or cosmetic in any 
    way contravened the provisions of that section; and
 </subsection><subsection>
<number>c</number>    that the drug or cosmetic, while in his 
    possession was properly stored and remained in the same state as when he 
    acquired it.]
 
 
 









 



</subsection></section></article> 
 
 
 
  
 

  
 <article>


    1[<number>20</number> Government 
    Analysts.—
<section><number>1</number> The State Government may, by notification in the Official 
    Gazette, appoint such persons as it thinks fit, having the prescribed 
    qualifications, to be Government Analysts for such areas in the State and in 
    respect of such drugs or 

    2[classes of drugs or 
    such cosmetics or classes of cosmetics] as may be specified in the 
    notifications.
 </section><section>
<number>2</number> The 
    Central Government may also, by notification in the Official Gazette, 
    appoint such persons as it thinks fit, having the prescribed qualifications, 
    to be Government Analysts in respect of such drugs or 

    2[classes of drugs or 
    such cosmetics or classes of cosmetics] as may be specified in the 
    notification.
 </section><section>
<number>3</number> 
    Notwithstanding anything contained in sub-section (1) or sub-section (2), 
    neither the Central Government nor a State Government shall appoint as a 
    Government Analyst any official not serving under it without the previous 
    consent of the Government under which he is serving.]
 


    3[(4) No person who 
    has any financial interest in the import, manufacture or sale of drugs or 
    cosmetics shall be appointed to be a Government Analyst under sub-section 
    (1) or sub-section (2) of this section.]
 
 
 






 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>21</number> Inspectors.—
<section><number>1</number> 
    The Central Government or a State Government may by notification in the 
    Official Gazette, appoint such persons as it thinks fit, having the 
    prescribed qualifications, to be Inspectors for such areas as may be 
    assigned to them by the Central Government or the State Government, as the 
    case may be.
 </section><section>
<number>2</number> The 
    powers which may be exercised by an Inspector and the duties which may be 
    performed by him, the drugs or 

    2[classes of drugs or 
    cosmetics or classes of cosmetics] in relation to which and the conditions, 
    limitations or restrictions subject to which, such powers and duties may be 
    exercised or performed shall be such as may be prescribed.
 </section><section>
<number>3</number> No 
    person who has any financial interest 

    3[in the import, 
    manufacture or sale of drugs or cosmetics] shall be appointed to be an 
    Inspector under this section.
 </section><section>
<number>4</number> 
    Every Inspector shall be deemed to be a public servant within the meaning of 
    section 21 of the Indian Penal Code (45 of 1860), and shall be officially 
    subordinate to such authority 

    4[, having the 
    prescribed qualifications,] as the Government appointing him may specify in 
    this behalf.]
 
 
 







 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>22</number> Powers of 
    Inspectors.—
<section><number>1</number> Subject to the provisions of section 23 and of any rules 
    made by the Central Government in this behalf, an Inspector may, within the 
    local limits of the area for which he is appointed,— 7[22. 
    Powers of Inspectors.—(1) Subject to the provisions of section 23 and of 
    any rules made by the Central Government in this behalf, an Inspector may, 
    within the local limits of the area for which he is appointed,—" 
 

2[(a)    
    inspect,—  
    1[(a) inspect,—" 
 <subsection>
<number>i</number>    any premises wherein any drug or 
    cosmetic is being manufactured and the means employed for standardising and 
    testing the drug or cosmetic;
 </subsection><subsection>
<number>ii</number>    any premises wherein any drug or 
    cosmetic is being sold, or stocked or exhibited or offered for sale, or 
    distributed;
 <subsubsection>
<number>b</number>    take samples of any drug or cosmetic,—
 </subsubsection></subsection><subsection>
<number>i</number>    which is being manufactured or being 
    sold or is stocked or exhibited or offered for sale, or is being 
    distributed;
 </subsection><subsection>
<number>ii</number>    from any person who is in the course 
    of conveying, delivering or preparing to deliver such drug or cosmetic to a 
    purchaser or a consignee;
 <subsubsection>
<number>c</number>    at all reasonable times, with such 
    assistance, if any, as he considers necessary,—
 </subsubsection></subsection><subsection>
<number>i</number>    search any person, who, he has reason 
    to believe, has secreted about his person, any drug or cosmetic in respect 
    of which an offence under this Chapter has been, or is being, committed; or
 </subsection><subsection>
<number>ii</number>    enter and search any place in which he 
    has reason to believe that an offence under this Chapter has been, or is 
    being, committed; or
 </subsection><subsection>
<number>iii</number>    stop and search any vehicle, vessel 
    or other conveyance which, he has reason to believe, is being used for 
    carrying any drug or cosmetic in respect of which an offence under this 
    Chapter has been, or is being, committed,
 
      and order in writing the person in 
    possession of the drug or cosmetic in respect of which the offence has been, 
    or is being, committed, not to dispose of any stock of such drug or cosmetic 
    for a specified period not exceeding twenty days, or, unless the alleged 
    offence is such that the defect may be removed by the possessor of the drug 
    or cosmetic, seize the stock of such drug or cosmetic and any substance or 
    article by means of which the offence has been, or is being, committed or 
    which may be employed for the commission of such offence;]
 

3[(cc) 
       examine any record, register, document or any other material object found
    4[with 
    any person, or in any place, vehicle, vessel or other conveyance referred to 
    in clause (c)], and seize the same if he has reason to believe that it may 
    furnish evidence of the commission of an offence punishable under this Act 
    or the Rules made thereunder;]  
    2[(cc) examine any record, register, document or any 
    other material object found 
3[with 
    any person, or in any place, vehicle, vessel or other conveyance referred to 
    in clause (c)], and seize the same if he has reason to believe that it may 
    furnish evidence of the commission of an offence punishable under this Act 
    or the Rules made thereunder;]" 
 

5[(cca)    
    require any person to produce any record, register, or other document 
    relating to the manufacture for sale or for distribution, stocking, 
    exhibition for sale, offer for sale or distribution of any drug or cosmetic 
    in respect of which he has reason to believe that an offence under this 
    Chapter has been, or is being, committed;]  
    4[(cca) require any person to produce any record, 
    register, or other document relating to the manufacture for sale or for 
    distribution, stocking, exhibition for sale, offer for sale or distribution 
    of any drug or cosmetic in respect of which he has reason to believe that an 
    offence under this Chapter has been, or is being, committed;]" 
 <subsubsection>
<number>d</number>    exercise such other powers as may be 
    necessary for carrying out the purposes of this Chapter or any rules made 
    thereunder.
 </subsubsection></subsection></section><section>
<number>2</number> The 
    provisions of 

    6[the Code of Criminal 
    Procedure, 1973 (2 of 1974)] shall, so far as may be, apply to any search or 
    seizure under this Chapter as they apply to any search or seizure made under 
    the authority of a warrant issued under 

    7[section 94] of the 
    said Code.
 


    8[(2A) Every record, 
    register or other document seized under clause (cc) or produced under clause 
    (cca) shall be returned to the person, from whom they were seized or who 
    produce the same, within a period of twenty days of the date of such seizure 
    or production, as the case may be, after copies thereof or extracts 
    therefrom certified by that person, in such manner as may be prescribed, 
    have been taken.] 3[(2A) 
    Every record, register or other document seized under clause (cc) or 
    produced under clause (cca) shall be returned to the person, from whom they 
    were seized or who produce the same, within a period of twenty days of the 
    date of such seizure or production, as the case may be, after copies thereof 
    or extracts therefrom certified by that person, in such manner as may be 
    prescribed, have been taken.]" 
 </section><section>
<number>3</number> If 
    any person wilfully obstructs an Inspector in the exercise of the powers 
    conferred upon him by or under this Chapter 

    8[or refuses to 
    produce any record, register or other document when so required under clause 
    (cca) of sub-section (1),] he shall be punishable with imprisonment which 
    may extend to three years, or with fine, or with both.]
 
 

 











 



</section></article> 
 
 
 
  
 

  
 <article>
<number>23</number> 
    Procedure of Inspectors.—
<section><number>1</number> 
    Where an Inspector takes any sample of a drug 

    1[or cosmetic] under 
    this Chapter, he shall tender the fair price thereof and may require a 
    written acknowledgement therefor.
 </section><section>
<number>2</number> 
    Where the price tendered under sub-section (1) is refused or where the 
    Inspector seizes the stock of any drug 

    1[or cosmetic] under 
    clause (c) of section 22, he shall tender a receipt therefor in the 
    prescribed form.
 </section><section>
<number>3</number> 
    Where an Inspector takes a sample of a drug 

    1[or cosmetic] for the 
    purpose of test or analysis, he shall intimate such purpose in writing in 
    the prescribed form to the person from whom he takes it and, in the presence 
    of such person unless he wilfully absents himself, shall divide the sample 
    into four portions and effectively seal and suitably mark the same and 
    permit such person to add his own seal and mark to all or any of the 
    portions so sealed and marked:
 
Provided 
    that where the sample is taken from premises whereon the drug 

    1[or cosmetic] is 
    being manufactured, it shall be necessary to divide the sample into three 
    portions only:
 
Provided 
    further that where the drug 

    1[or cosmetic] is made 
    up in containers of small volume, instead of dividing a sample as aforesaid, 
    the Inspector may, and if the drug 

    1[or cosmetic] be such 
    that it is likely to deteriorate or be otherwise damaged by exposure shall, 
    take three or four, as the case may be, of the said containers after 
    suitably marking the same and, where necessary, sealing them.
 </section><section>
<number>4</number> The 
    Inspector shall restore one portion of a sample so divided or one container, 
    as the case may be, to the person from whom he takes it, and shall retain 
    the remainder and dispose of the same as follows:—
 <subsection>
<number>i</number>    one portion or container he shall 
    forthwith send to the Government Analyst for test or analysis;
 </subsection><subsection>
<number>ii</number>    the second he shall produce to 
    the Court before which proceedings, if any, are instituted in respect of the 
    drug 1[or 
    cosmetic]; and 
 

2[(iii)    
    the third, where taken, he shall send to the person, if any, whose name, 
    address and other particulars have been disclosed under section 18A.] 
 </subsection></section><section>
<number>5</number> 
    Where an Inspector takes any action under clause (c) of section 22,—
 <subsection>
<number>a</number>    he shall use all despatch in 
    ascertaining whether or not the drug 
1[or 
    cosmetic] contravenes any of the provisions of section 18 and, if it is 
    ascertained that the drug 
1[or 
    cosmetic] does not so contravene forthwith revoke the order passed under the 
    said clause or, as the case may be, take such action as may be necessary for 
    the return of the stock seized;
 </subsection><subsection>
<number>b</number>    if he seizes the stock of the 
    drug 1[or 
    cosmetic], he shall as soon as may be, inform 
3[a 
    Judicial Magistrate] and take his orders as to the custody thereof;
 </subsection><subsection>
<number>c</number>    without prejudice to the 
    institution of any prosecution, if the alleged contravention be such that 
    the defect may be remedied by the possessor of the drug 
1[or 
    cosmetic], he shall, on being satisfied that the defect has been so 
    remedied, forthwith revoke his order under the said clause.
 


    4[(6) Where an 
    Inspector seizes any record, register, document or any other material object 
    under clause (cc) of sub-section (1) of section 22, he shall, as soon as may 
    be, inform 

    3[a Judicial 
    Magistrate] and take his orders as to the custody thereof.] 4[(6) 
    Where an Inspector seizes any record, register, document or any other 
    material object under clause (cc) of sub-section (1) of section 22, he 
    shall, as soon as may be, inform 

    3[a Judicial 
    Magistrate] and take his orders as to the custody thereof.]" 
 
 

 







 



</subsection></section></article> 
 
 
 
  
 

  
 <article>
<number>24</number> 
    Persons bound to disclose place where drugs or cosmetics are manufactured or 
    kept.—Every 
    person for the time being in charge of any premises whereon any drug 


    1[or cosmetic] is 
    being manufactured or is kept for sale or distribution shall, on being 
    required by any Inspector so to do, be legally bound to disclose to the 
    Inspector the place where the drug 

    1[or cosmetic] is 
    being manufactured or is kept, as the case may be. 
 





 



</article> 

  
  
 <article><title><number>25</number> Reports of Government Analysts. </title>—
<section><number>1</number> The Government 
Analyst to whom a sample of any drug <footcitenum>116</footcitenum>[or cosmetic] has been 
submitted for test or analysis under sub-section (4) of section 23, shall 
deliver to the Inspector submitting it a signed report in triplicate in the 
prescribed form. 
 </section><section><number>2</number> The Inspector on receipt thereof shall deliver one copy of the report to 
the person from whom the sample was taken <footcitenum>117</footcitenum>[and another copy to the 
person, if any, whose name, address and other particulars have been disclosed 
under section 18A], and shall retain the third copy for use in any prosecution 
in respect of the sample. 
 </section><section><number>3</number> Any document purporting to be a report signed by a Government Analyst 
under this Chapter shall be evidence of the facts stated therein, and such 
evidence shall be conclusive unless the person from whom the sample was taken 
<footcitenum>118</footcitenum>[or the person whose name, address and other particulars have been 
disclosed under section 18A] has, within twenty-eight days of the receipt of a 
copy of the report, notified in writing the Inspector or the Court before which 
any proceedings in respect of the sample are pending that he intends to adduce 
evidence in controversion of the report. 
 </section><section><number>4</number> Unless the sample has already been tested or analysed in the Central 
Drugs Laboratory, where a person has under sub-section (3) notified his 
intention of adducing evidence in controversion of a Government Analyst's 
report, the Court may, of its own motion or in its discretion at the request 
either of the complainant or the accused: cause the sample of the drug 
<footcitenum>116</footcitenum>[or cosmetic] produced before the Magistrate under sub-section (4) 
of section 23 to be sent for test or analysis to the said Laboratory, which 
shall make the test or analysis and report in writing signed by or under the 
authority of, the Director of the Central Drugs Laboratory the result thereof, 
and such report shall be conclusive evidence of the facts stated therein. 
 </section><section><number>5</number> The cost of a test or analysis made by the Central Drugs Laboratory under 
sub-section (4) shall be paid by the complainant or accused as the Court shall 
direct. 










</section></article> 
 
 
 
  
 

  
 <article>
<number>26</number> 
    Purchaser of drug or cosmetic enabled to obtain test or analysis.—Any 
    person 

    1[or any recognised 
    consumer association, whether such person is a member of that association or 
    not] shall, on application in the prescribed manner and on payment of the 
    prescribed fee, be entitled to submit for test or analysis to a Government 
    Analyst any drug 

    2[or cosmetic] 


    3[purchased by him or 
    it] and to receive a report of such test or analysis signed by the 
    Government Analyst.
 


    4[Explanation.—For 
    the purposes of this section and section 32, “recognised consumer 
    association” means a voluntary consumer association registered under the 
    Companies Act, 1956 or any other law for the time being in force.]
 
 







 



</article> 

  
 <article><footcitenum>123</footcitenum>[<title><number>26A</number>Powers of Central Government to prohibit 
manufacture, etc., of drug and cosmetic in public interest. </title>—Without 
prejudice to any other provision contained in this Chapter, if the Central 
Government is satisfied, that the use of any drug or cosmetic is likely to 
involve any risk to human beings or animals or that any drug does not have the 
therapeutic value claimed or purported to be claimed for it or contains 
ingredients and in such quantity for which there is no therapeutic justification 
and that in the public interest it is necessary or expedient so to do, then, 
that Government may, by notification in the Official Gazette, 
<footcitenum>124</footcitenum>[regulate, restrict or prohibit] the manufacture, sale or 
distribution of such drug or cosmetic.] 





</article> 

  
 <article><footcitenum>125</footcitenum>[<title><number>26B</number>Power of Central Government to regulate or restrict, 
manufacture, etc., of drug in public interest. </title>—Without prejudice to 
any other provision contained in this Chapter, if the Central Government is 
satisfied that a drug is essential to meet the requirements of an emergency 
arising due to epidemic or natural calamities and that in the public interest, 
it is necessary or expedient so to do, then, that Government may, by 
notification in the Official Gazette, regulate or restrict the manufacture, sale 
or distribution of such drug.] 

</article> 

  
 <article><footcitenum>126</footcitenum>[<title>27</title>.[<title>Penalty for manufacture, sale, 
etc., of drugs in contravention of this Chapter. </title>—Whoever, himself or 
by any other person on his behalf, manufactures for sale or for distribution, or 
sells, or stocks or exhibits or offers for sale or distributes,— 
 <section><number>a</number> any drug deemed to be adulterated under section 17A or spurious under 
section <footcitenum>127</footcitenum>[17B and which] when used by any person for or in the 
diagnosis, treatment, mitigation, or prevention of any disease or disorder is 
likely to cause his death or is likely to cause such harm on his body as would 
amount to grievous hurt within the meaning of section 320 of the Indian Penal 
Code (45 of 1860), solely on account of such drug being adulterated or spurious 
or not of standard quality, as the case may be, shall be <footcitenum>128</footcitenum>[punishable 
with imprisonment for a term which shall not be less than ten years but which 
may extend to imprisonment for life and shall also be liable to fine which shall 
not be less than ten lakh rupees or three times value of the drugs confiscated, 
whichever is more:] 
 <footcitenum>129</footcitenum>[Provided that the fine imposed on and released from, the person 
convicted under this clause shall be paid, by way of compensation, to the person 
who had used the adulterated or spurious drugs referred to in this clause: 
 Provided further that where the use of the adulterated or spurious drugs 
referred to in this clause has caused the death of a person who used such drugs, 
the fine imposed on and realised from, the person convicted under this clause, 
shall be paid to the relative of the person who had died due to the use of the 
adulterated or spurious drugs referred to in this clause. 
 Explanation .—For the purposes of the second proviso, the expression 
“relative” means— 
 
 <subsection><number>i</number> spouse of the deceased person; or 
 </subsection><subsection><number>ii</number> a minor legitimate son, and unmarried legitimate daughter and a 
  widowed mother; or 
 </subsection><subsection><number>iii</number> parent of the minor victim; or 
 </subsection><subsection><number>iv</number> if wholly dependent on the earnings of the deceased person at the time 
  of his death, a son or a daughter who has attained the age of eighteen years; 
  or 
 </subsection><subsection><number>v</number> any person, if wholly or in part, dependent on the earnings of the 
  deceased person at the time of his death,— 
 
 <subsubsection><number>a</number> the parent; or 
 </subsubsection><subsubsection><number>b</number> a minor brother or an unmarried sister; or 
 </subsubsection><subsubsection><number>c</number> a widowed daughter-in-law; or 
 </subsubsection><subsubsection><number>d</number> a widowed sister; or 
 </subsubsection><subsubsection><number>e</number> a minor child of a pre-deceased son; or 
 </subsubsection><subsubsection><number>f</number> a minor child of a pre-deceased daughter where no parent of the child 
    is alive; or 
 </subsubsection><subsubsection><number>g</number> the paternal grandparent if no parent of the member is alive;] 
 
 </subsubsection><subsubsection><number>b</number> any drug— 
 
 
 Provided that the Court may, for any adequate and special reasons to be 
      recorded in the judgment, impose a sentence of imprisonment for a term of 
      <footcitenum>131</footcitenum>[less than three years and of fine of less than one lakh 
      rupees]; 
 </subsubsection><subsubsection><number>c</number> any drug deemed to be spurious under section 17B, but not being a 
      drug referred to in clause (a) shall be punishable with imprisonment for a 
      term which shall <footcitenum>132</footcitenum>[not be less than seven years but which may 
      extend to imprisonment for life and with fine which shall not be less than 
      three lakh rupees or three times the value of the drugs confiscated, 
      whichever is more]: 
 Provided that the Court may, for any adequate and special reasons, to 
      be recorded in the judgment, impose a sentence of imprisonment for a term 
      of <footcitenum>133</footcitenum>[less than seven years but not less than three years and of 
      fine of less than one lakh rupees]; 
 </subsubsection><subsubsection><number>d</number> any drug, other than a drug referred to in clause (a) or clause (b) 
      or clause (c), in contravention of any other provision of this Chapter or 
      any rule made thereunder, shall be punishable with imprisonment for a term 
      which shall not be less than one year but which may extend to two years 
      <footcitenum>134</footcitenum>[and with fine which shall not be less than twenty thousand 
      rupees]: 
 Provided that the Court may for any adequate and special reasons to be 
      recorded in the judgment impose a sentence of imprisonment for a term of 
      less than one year. </subsubsection>
 <title>COMMENTS </title></subsection><subsection><number>i</number> deemed to be adulterated under section 17A, but not being a drug 
        referred to in clause (a), or 
 </subsection><subsection><number>ii</number> without a valid licence as required under clause (c) of section 
        18, shall be punishable with imprisonment for a term which shall 
        <footcitenum>130</footcitenum>[not be less than three years but which may extend to five 
        years and with fine which shall not be less than one lakh rupees or 
        three times the value of the drugs confiscated, whichever is more]: 
      </subsection>
 The absence of any comma after the word “stocks” clearly indicates 
that the clause “stocks or exhibits for sale” is one indivisible whole and it 
contemplates not merely stocking the drugs but stocking the drugs for the 
purposes of sale and unless all the ingredients of this category are satisfied, 
section 27 of the Act would not be attracted; Mohd Shabir v. State 
of Maharashtra , (1979) 1 SCC 568. 









</section></article> 

  
 <article><footcitenum>135</footcitenum>[<title><number>27A</number> Penalty for manufacture, sale, etc., of cosmetics 
in contravention of this Chapter. </title>—Whoever himself or by any other 
person on his behalf manufactures for sale or for distribution, or sells, or 
stocks or exhibits or offers for sale— 
 <section><footcitenum>136</footcitenum>[<number>i</number> any cosmetic deemed to be spurious under section 17D or 
adulterated under section 17E shall be punishable with imprisonment for a term 
which may extend to three years and with fine which shall not be less than fifty 
thousand rupees or three times to value of the cosmetics confiscated, whichever 
is more; 
 </section><section><number>ii</number> any cosmetic other than a cosmetic referred to in clause (i) in 
contravention of any provisions of this Chapter or any rule made thereunder 
shall be punishable with imprisonment for a term which may extend to one year or 
with fine which may extend to twenty thousand rupees, or with both.] 





</section></article> 

  
 <article><footcitenum>137</footcitenum>[<title><number>28</number> Penalty for non-disclosure of the name of the 
manufacturer, etc. </title>—Whoever contravenes the provisions of section 18A 
<footcitenum>138</footcitenum>[or section 24] shall be punishable with imprisonment for a term 
which may extend to one year, or <footcitenum>139</footcitenum>[with fine which shall not be less 
than twenty thousand rupees or with both.] 




</article> 

  
 <article><footcitenum>140</footcitenum>[<title><number>28A</number> Penalty for not keeping documents, etc., and for 
non-disclosure of information. </title>—Whoever without reasonable cause or 
excuse, contravenes the provisions of section 18B shall be punishable with 
imprisonment for a term which may extend to one year or <footcitenum>141</footcitenum>[with fine 
which shall not be less than twenty thousand rupees or with both].] 



</article> 
 
 
 
  
 

  
 <article>


    1[<number>28B</number> Penalty for 
    manufacture, etc., of drugs or cosmetics in contravention of section 26A.—Whoever 
    himself or by any other person on his behalf manufactures or sells or 
    distributes any drug or cosmetic in contravention of the provisions of any 
    notification issued under section 26A, shall be punishable with imprisonment 
    for a term which may extend to three years and shall also be liable to fine 
    which may extend to five thousand rupees.]
 
 




 



</article> 

  
 <article><title><number>29</number> Penalty for use of Government Analyst's report for advertising. 
</title>—Whoever uses any report of a test or analysis made by the Central 
Drugs Laboratory or by a Government Analyst, or any extract from such report, 
for the purpose of advertising any drug <footcitenum>143</footcitenum>[or cosmetic], shall be 
punishable with fine which may extend to <footcitenum>144</footcitenum>[five thousand rupees]. 




</article> 

  
 <article><footcitenum>145</footcitenum>[<title><number>30</number> Penalty for subsequent offences. </title>— 
<footcitenum>146</footcitenum>[
<section><number>1</number> Whoever having been convicted of an offence,— 
 
 <subsection><number>a</number> under clause (b) of section 27 is again convicted of an offence under 
  that clause, shall be punishable with imprisonment for a term which shall 
  <footcitenum>147</footcitenum>[not be less than seven years but which may extend to ten years 
  and with fine which shall not be less than two lakh rupees]: </subsection>
 Provided that the Court may, for any adequate and special reasons to be 
mentioned in the judgment, impose a sentence of imprisonment for a term of 
<footcitenum>148</footcitenum>[less than seven years and of fine of less than one lakh rupees]; 

 
 <subsection><number>b</number> under clause (c) of section 27, is again convicted of an offence under 
  that clause shall be punishable with imprisonment for a term which 
  <footcitenum>149</footcitenum>[shall not be less than ten years but which may extend to 
  imprisonment for life and with fine which shall not be less than three lakh 
  rupees]; </subsection>
 <subsection><number>c</number> under clause (d) of section 27, is again convicted of an offence under 
that clause shall be punishable with imprisonment for a term which shall not be 
less than two years but which may extend to four years or with fine which shall 
not be less than <footcitenum>150</footcitenum>[fifty thousand rupees], or with both.] 
 </subsection></section><section><footcitenum>151</footcitenum>[<number>1A</number> Whoever, having been convicted of an offence under section 
27A is again convicted under that section, shall be punishable with imprisonment 
for a term which may extend to two years, or with fine which may extend to 
<footcitenum>152</footcitenum>[two thousand rupees], or with both.] 
 </section><section><number>2</number> Whoever, having been convicted of an offence under <footcitenum>153</footcitenum>[***] 
section 29 is again convicted of an offence under the same section, shall be 
punishable with imprisonment which may extend to <footcitenum>154</footcitenum>[two years, or 
with fine which shall not be less than ten thousand rupees or with both]. 












</section></article> 
 
 
 
  
 

  
 <article>
<number>31</number> 
    Confiscation.—1[
<section><number>1</number>] 
    Where any person has been convicted under this Chapter for contravening any 
    such provision of this Chapter or any rule made thereunder as may be 
    specified by rule made in this behalf, the stock of the drug 

    2[or cosmetic] in 
    respect of which the contravention has been made shall be liable to 
    confiscation 

    3[and if such 
    contravention is in respect of—
 

4[(i)    
    manufacture of any drug deemed to be misbranded under section 17, 
    adulterated under section 17A or spurious under section 17B; or] 
 <subsection>
<number>ii</number>    
5[manufacture 
    for sale, or for distribution, sale, or stocking or exhibiting or offering 
    for sale,] or distribution of any drug without a valid licence as required 
    under clause (c) of section 18,
 
any implements or machinery used in such 
    manufacture, sale or distribution and any receptacles, packages or coverings 
    in which such drug is contained and the animals, vehicles, vessels or other 
    conveyances used in carrying such drug shall also be liable to 
    confiscation].
 


    6[(2) Without 
    prejudice to the provisions contained in sub-section (1) where the Court is 
    satisfied, on the application of an Inspector or otherwise and after such 
    inquiry as may be necessary that the drug or cosmetic is not of standard 
    quality 

    7[or is a 


    8[misbranded, 
    adulterated or spurious drug or misbranded or spurious cosmetic,]] such drug 
    or, as the case may be, such cosmetic shall be liable to confiscation.]
 
 











 



</subsection></section></article> 
 
 
 
  
 

  
 <article>


    1[<number>31A</number> Application 
    of provisions to Government departments.—The provisions of this Chapter 
    except those contained in section 31 shall apply in relation to the 
    manufacture, sale or distribution of drugs by any department of Government 
    as they apply in relation to the manufacture, sale or distribution of drugs 
    by any other person.] 
 
 




 



</article> 

  
 <article><title><number>32</number> Cognizance of offences. </title>— <footcitenum>164</footcitenum>[
<section><number>1</number> No 
prosecution under this Chapter shall be instituted except by— 
 
 <subsection><number>a</number> an Inspector; or 
 </subsection><subsection><number>b</number> any gazetted officer of the Central Government or a State Government 
  authorised in writing in this behalf by the Central Government or a State 
  Government by a general or special order made in this behalf by that 
  Government; or 
 </subsection><subsection><number>c</number> the person aggrieved; or 
 </subsection><subsection><number>d</number> a recognised consumer association whether such person is a member of 
  that association or not. </subsection>
 </section><section><number>2</number> Save as otherwise provided in this Act, no court inferior to that of a 
Court of Session shall try an offence punishable under this Chapter.] 
 </section><section><number>3</number> Nothing contained in this Chapter shall be deemed to prevent any person 
from being prosecuted under any other law for any act or omission which 
constitutes an offence against this Chapter. 

</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>32A</number> Power of 
    Court to implead the manufacturer, etc.—Where, at any time during the 
    trial of any offence under this Chapter alleged to have been committed by 
    any person, not being the manufacturer of a drug or cosmetic or his agent 
    for the distribution thereof the Court is satisfied, on the evidence adduced 
    before it, that such manufacturer or agent is also concerned in that 
    offence, then, the Court may, notwithstanding anything contained 


    2[in sub-sections 
    
<section><number>1</number>, (2) and (3) of section 319 of the Code of Criminal Procedure, 1973 (2 
    of 1974)], proceed against him as though a prosecution had been instituted 
    against him under section 32.
 
 
 





 



</section></article> 

  
 <article><footcitenum>167</footcitenum><title>[<number>32B</number> Compounding of certain offences. </title>— 

<section><number>1</number> Notwithstanding anything contained in the Code of Criminal Procedure, 
1973 (2 of 1974), any offence punishable under clause (b) of sub-section (1) of 
section 13, section 28 and section 28A of this Act (whether committed by a 
company or any officer thereof), not being an offence punishable with 
imprisonment only, or with imprisonment and also with fine, may, either before 
or after the institution of any prosecution, be compounded by the Central 
Government or by any State Government or any officer authorised in this behalf 
by the Central Government or a State Government, on payment for credit to that 
Government of such sum as that Government may, by rules made in this behalf, 
specify: 
 Provided that such sum shall not, in any case, exceed the maximum 
amount of the fine which may be imposed under this Act for the offence so 
compounded: 
 Provided further that in cases of subsequent offences, the same 
shall not be compoundable. 
 </section><section><number>2</number> When the accused has been committed for trial or when he has 
been convicted and an appeal is pending, no composition for the offence shall be 
allowed without the leave of the court to which he is committed or, as the case 
may be, before which the appeal is to be heard. 
 </section><section><number>3</number> Where an offence is compounded under sub-section (1), no 
proceeding or further proceeding, as the case may be, shall be taken against the 
offender in respect of the offence so compounded and the offender, if in 
custody, shall be released forthwith.] 

</section></article> 

  
 <article><title><number>33</number> Power of Central Government to make rules. </title>— 
<footcitenum>168</footcitenum>[
<section><number>1</number> The Central Government may <footcitenum>169</footcitenum>[after consultation 
with, or on the recommendation of, the Board] and after previous publication by 
notification in the Official Gazette, make rules for the purposes of giving 
effect to the provisions of this Chapter: 
 Provided that consultation with the Board may be dispensed with if the 
Central Government is of opinion that circumstances have arisen which render it 
necessary to make rules without such consultation, but in such a case the Board 
shall be consulted within six months of the making of the rules and the Central 
Government shall take into consideration any suggestions which the Board may 
make in relation to the amendment of the said rules.] 
 </section><section><number>2</number> Without prejudice to the generality of the foregoing power, such rules 
may— 
 
 <subsection><number>a</number> provide for the establishment of laboratories for testing and analysing 
  drugs <footcitenum>170</footcitenum>[or cosmetics]; 
 </subsection><subsection><number>b</number> prescribe the qualifications and duties of Government Analysts and the 
  qualifications of Inspectors; 
 </subsection><subsection><number>c</number> prescribe the methods of test or analysis to be employed in determining 
  whether a drug <footcitenum>170</footcitenum>[or cosmetic] is of standard quality; 
 </subsection><subsection><number>d</number> prescribe, in respect of biological and organometallic compounds, the 
  units or methods of standardisation; 
 </subsection><subsection><footcitenum>171</footcitenum>[<number>dd</number> prescribe under clause (d) of <footcitenum>172</footcitenum>[section 17A] 
  the colour or colours which a drug may bear or contain for purposes of 
  colouring;] 
 </subsection><subsection><footcitenum>173</footcitenum>[<number>dda</number> prescribe under clause (d) of section 17E the colour or 
  colours which a cosmetic may bear or contain for the purposes of colouring;] 
  
 </subsection><subsection><number>e</number> prescribe the forms of licences <footcitenum>174</footcitenum>[for the manufacture for 
  sale or for distribution], for the sale and for the distribution of drugs or 
  any specified drug or class of drugs <footcitenum>175</footcitenum>[or of cosmetics or any 
  specified cosmetic or class of cosmetics], the form of application for such 
  licences, the conditions subject to which such licences may be issued, the 
  authority empowered to issue the same <footcitenum>176</footcitenum>[the qualifications of such 
  authority] and the fees payable therefor; <footcitenum>176</footcitenum>[and provide for the 
  cancellation or suspension of such licences in any case where any provision of 
  this Chapter or the rules made thereunder is contravened or any of the 
  conditions subject to which they are issued is not complied with]; 
 </subsection><subsection><footcitenum>176</footcitenum>[<number>ee</number> prescribe the records, registers or other documents to be 
  kept and maintained under section 18B;] 
 </subsection><subsection><footcitenum>176</footcitenum>[<number>eea</number> prescribe the fees for the inspection (for the purposes 
  of grant or renewal of licences) of premises, wherein any drug or cosmetic is 
  being or is proposed to be manufactured;] 
 </subsection><subsection><footcitenum>176</footcitenum>[<number>eeb</number> prescribe the manner in which copies are to be certified 
  under sub-section (2A) of section 22;] 
 </subsection><subsection><number>f</number> specify the diseases or ailments which a drug may not purport or claim 
  <footcitenum>177</footcitenum>[to prevent, cure or mitigate] and such other effects which a 
  drug may not purport or claim to have; 
 </subsection><subsection><number>g</number> prescribe the conditions subject to which small quantities of drugs may 
  be manufactured for the purpose of examination, test or analysis; 
 </subsection><subsection><number>h</number> require the date of manufacture and the date of expiry of potency to be 
  clearly and truly stated on the label or container of any specified drug or 
  class of drugs, and prohibit the sale, stocking or exhibition for sale, or 
  distribution of the said drug or class of drugs after the expiry of a 
  specified period from the date of manufacture or after the expiry of the date 
  of potency; 
 </subsection><subsection><number>i</number> prescribe the conditions to be observed in the packing in bottles, 
  packages, and other containers of drugs <footcitenum>175</footcitenum>[or cosmetics], 
  <footcitenum>176</footcitenum>[including the use of packing material which comes into direct 
  contact with the drugs] and prohibit the sale, stocking or exhibition for 
  sale, or distribution of drugs <footcitenum>175</footcitenum>[or cosmetics] packed in 
  contravention of such conditions; 
 </subsection><subsection><number>j</number> regulate the mode of labelling packed drugs <footcitenum>175</footcitenum>[or cosmetics], 
  and prescribe the matters which shall or shall not be included in such labels; 
  
 </subsection><subsection><number>k</number> prescribe the maximum proportion of any poisonous substance which may 
  be added to or contained in any drug, prohibit the manufacture, sale or 
  stocking or exhibition for sale, or distribution of any drug in which that 
  proportion is exceeded, and specify substances which shall be deemed to be 
  poisonous for the purposes of this Chapter and the rules made thereunder; 
 </subsection><subsection><number>l</number> require that the accepted scientific name of any specified drug shall 
  be displayed in the prescribed manner on the label or wrapper of any patent or 
  proprietary medicine containing such drug; 
 <footcitenum>178</footcitenum>[***] 
 </subsection><subsection><footcitenum>179</footcitenum>[<number>n</number> prescribe the powers and duties of Inspectors 
  <footcitenum>180</footcitenum>[and the qualifications of the authority to which such Inspectors 
  shall be subordinate] and <footcitenum>181</footcitenum>[specify the drugs or classes of drugs 
  or cosmetics or classes of cosmetics] in relation to which and the conditions, 
  limitations or restrictions subject to which, such powers and duties may be 
  exercised or performed;] 
 </subsection><subsection><number>o</number> prescribe the forms of report to be given by Government 
  Analysts, and the manner of application for test or analysis under section 26 
  and the fees payable therefor; 
 </subsection><subsection><footcitenum>182</footcitenum>[<number>p</number> specify the offences against this Chapter or any rule 
  made thereunder in relation to which an order of confiscation may be made 
  under section 31; <footcitenum>183</footcitenum>[***]] 
 </subsection><subsection><number>q</number> provide for the exemption, conditionally or otherwise, from 
  all or any of the provisions of this Chapter or the rules made thereunder, of 
  any specified drug or class of drugs <footcitenum>184</footcitenum>[or cosmetic or class of 
  cosmetics]; <footcitenum>185</footcitenum>[and] 
 </subsection><subsection><footcitenum>186</footcitenum>[<number>r</number> sum which may be specified by the Central Government 
  under section 32B.] 
 <footcitenum>187</footcitenum>[***] 
 <title>COMMENTS </title></subsection>
 It was obligatory on the part of the rule making authority to 
satisfy the Court that it was necessary in the facts and circumstances of the 
case to enhance the fees payable for the renewal of licence in the manner as has 
been sought to be done; Jaiswal Medical Hall v. Union of India, 
AIR 1988 Pat 266. 




















</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>33A</number> 
    Chapter not to apply to 

    2[Ayurvedic, Siddha or 
    Unani] drugs.—Save 
    as otherwise provided in this Act, nothing contained in this Chapter shall 
    apply to 

    2[Ayurvedic, Siddha or 
    Unani] drugs.]
 
  




 



</article> 
 
 
 
  
 

  
 <article>
<number>33B</number> 
    Application of Chapter IVA.—This 
    Chapter shall apply only to 

    1[Ayurvedic, Siddha 
    and Unani] drugs.
 





 



</article> 
 
 
 
  
 

  
 <article>
<number>33C</number> 
    Ayurvedic and Unani Drugs Technical Advisory Board.—
<section><number>1</number> 
    The Central Government shall, by notification in the Official Gazette and 
    with effect from such date as may be specified therein, constitute a Board 
    (to be called the 

    1[Ayurvedic, Siddha 
    and Unani Drugs Technical Advisory Board]) to advise the Central Government 
    and the State Governments on technical matters arising out of this Chapter 
    and to carry out the other functions assigned to it by this Chapter.
 </section><section>
<number>2</number> The 
    Board shall consist of the following members, namely,—
 <subsection>
<number>i</number>    the Director General of Health 
    Services, ex officio;
 </subsection><subsection>
<number>ii</number>    the Drugs Controller, India, ex 
    officio;
 

2[(iii)    
    the principal officer dealing with Indian systems of medicine in the 
    Ministry of Health, ex officio;]
 </subsection><subsection>
<number>iv</number>    the Director of the Central Drugs 
    Laboratory, Calcutta, ex officio;
 </subsection><subsection>
<number>v</number>    one person holding the appointment of 
    Government Analyst under section 33F, to be nominated by the Central 
    Government;
 </subsection><subsection>
<number>vi</number>    one Pharmacognocist to be nominated by 
    the Central Government;
 </subsection><subsection>
<number>vii</number>    one Phyto-chemist to be nominated by 
    the Central Government;
 

3[(viii)    
    four persons to be nominated by the Central Government, two from amongst the 
    members of the Ayurvedic Pharmacopoeia Committee, one from amongst the 
    members of Unani Pharmacopoeia Committee and one from amongst the members of 
    the Siddha Pharmacopoeia Committee;]
 </subsection><subsection>
<number>ix</number>    one teacher in Darvyaguna and 
    Bhaishajya Kalpana, to be nominated by the Central Government;
 </subsection><subsection>
<number>x</number>    one teacher in Ilm-ul-Advia and 
    Taklis-Wa-Dawa-Sazi, to be nominated by the Central Government;
 

4[(xi)    
    one teacher in Gunapadam to be nominated by the Central Government;  
    2[(xi) one teacher in Gunapadam to be nominated by the 
    Central Government;" 
 <subsubsection>
<number>xii</number>    three persons, one each to represent 
    the Ayurvedic, Siddha and Unani drug industry, to be nominated by the 
    Central Government;
 </subsubsection><subsubsection>
<number>xiii</number>    three persons, one each from amongst 
    the practitioners of Ayurvedic, Siddha and Unani Tibb systems of medicine to 
    be nominated by the Central Government.] 
 </subsubsection></subsection></section><section>
<number>3</number> The 
    Central Government shall appoint a member of the Board as its Chairman.
 </section><section>
<number>4</number> The 
    nominated members of the Board shall hold office for three years but shall 
    be eligible for renomination.
 </section><section>
<number>5</number> The 
    Board may, subject to the previous approval of the Central Government, make 
    bye-laws fixing quorum and regulating its own procedure and conduct of all 
    business to be transacted by it.
 </section><section>
<number>6</number> The 
    functions of the Board may be exercised notwithstanding any vacancy therein.
 </section><section>
<number>7</number> The 
    Central Government shall appoint a person to be Secretary of the Board and 
    shall provide the Board with such clerical and other staff as the Central 
    Government considers necessary.
 
 







 



</section></article> 
 
 
 
  
 

  
 <article>


    1[<number>33D</number> The 
    Ayurvedic, Siddha and Unani Drugs Consultative Committee.—
<section><number>1</number> The 
    Central Government may constitute an Advisory Committee to be called the 
    Ayurvedic, Siddha and Unani Drugs Consultative Committee to advise the 
    Central Government, the State Governments and the Ayurvedic, Siddha and 
    Unani Drugs Technical Advisory Board on any matter for the purpose of 
    securing uniformity throughout India in the administration of this Act in so 
    far as it relates to Ayurvedic, Siddha or Unani drugs. 
 </section><section>
<number>2</number> The 
    Ayurvedic, Siddha and Unani Drugs Consultative Committee shall consist of 
    two persons to be nominated by the Central Government as representatives of 
    that Government and not more than one representative of each State to be 
    nominated by the State Government concerned.
 </section><section>
<number>3</number> The 
    Ayurvedic, Siddha and Unani Drugs Consultative Committee shall meet when 
    required to do so by the Central Government and shall regulate its own 
    procedure.]
  




 



</section></article> 
 
 
 
  
 

  
 <article>

<footcitenum>196</footcitenum>[<number>33E</number> 
    Misbranded drugs.—For 
    the purposes of this Chapter, an Ayurvedic, Siddha or Unani drug shall be 
    deemed to be misbranded—
 <section>
<number>a</number>    if it is so coloured, coated, powdered 
    or polished that damage is concealed, or if it is made to appear of better 
    or greater therapeutic value than it really is; or
 </section><section>
<number>b</number>    if it is not labelled in the prescribed 
    manner; or
 </section><section>
<number>c</number>    if its label or container or anything 
    accompanying the drug bears any statement, design or device which makes any 
    false claim for the drug or which is false or misleading in any particular.]
 




 



</section></article> 
 
 
 
  
 

  
 <article>

<footcitenum>197</footcitenum>[<number>33EE</number> 
    Adulterated drugs.—For 
    the purposes of this Chapter, an Ayurvedic, Siddha or Unani drug shall be 
    deemed to be adulterated,—
 <section>
<number>a</number>    if it consists, in whole or in part, of 
    any filthy, putrid or decomposed substance; or
 </section><section>
<number>b</number>    if it has been prepared, packed or 
    stored under insanitary conditions whereby it may have been contaminated 
    with filth or whereby it may have been rendered injurious to health; or
 </section><section>
<number>c</number>    if its container is composed, in whole 
    or in part, of any poisonous or deleterious substance which may render the 
    contents injurious to health; or
 </section><section>
<number>d</number>    if it bears or contains, for purposes 
    of colouring only, a colour other than one which is prescribed; or
 </section><section>
<number>e</number>    if it contains any harmful or toxic 
    substance which may render it injurious to health; or
 </section><section>
<number>f</number>    if any substance has been mixed 
    therewith so as to reduce its quality or strength.
 

    Explanation.—For 
    the purpose of clause (a), a drug shall not be deemed to consist, in whole 
    or in part, of any decomposed substance only by reason of the fact that such 
    decomposed substance is the result of any natural decomposition of the drug:
 
Provided 
    that such decomposition is not due to any negligence on the part of the 
    manufacturer of the drug or the dealer thereof and that it does not render 
    the drug injurious to health.]
 




 



</section></article> 
 
 
 
  
 

  
 <article>

<footcitenum>198</footcitenum>[<number>33EEA</number> Spurious drugs.—For 
    the purposes of this Chapter, an Ayurvedic, Siddha or Unani drug shall be 
    deemed to be spurious—
 <section>
<number>a</number>    if it is sold, or offered or exhibited 
    for sale, under a name which belongs to another drug; or
 </section><section>
<number>b</number>    if it is an imitation of, or is a 
    substitute for, another drug or resembles another drug in a manner likely to 
    deceive, or bears upon it or upon its label or container the name of another 
    drug, unless it is plainly and conspicuously marked so as to reveal its true 
    character and its lack of identity with such other drug; or
 </section><section>
<number>c</number>    if the label or container bears the 
    name of an individual or company purporting to be the manufacturer of the 
    drug, which individual or company is fictitious or does not exist; or
 </section><section>
<number>d</number>    if it has been substituted wholly or in 
    part by any other drug or substance; or
 </section><section>
<number>e</number>    if it purports to be the product of a 
    manufacturer of whom it is not truly a product.]
 




 



</section></article> 
 
 
 
  
 

  
 <article>

<footcitenum>199</footcitenum>[<number>33EEB</number> Regulation of manufacture for sale of Ayurvedic, Siddha and Unani 
    drugs.—No 
    person shall manufacture for sale or for distribution any Ayurvedic, Siddha 
    or Unani drug except in accordance with such standards, if any, as may be 
    prescribed in relation to that drug.]
 




 



</article> 
 
 
 
  
 

  
 <article>

<footcitenum>200</footcitenum>[<number>33EEC</number> Prohibition of manufacture and sale of certain Ayurvedic, Siddha and 
    Unani drugs.—From 
    such date as the State Government may, by notification in the Official 
    Gazette, specify in this behalf, no person, either by himself or by any 
    other person on his behalf, shall—
 <section>
<number>a</number>    manufacture for sale or for 
    distribution—
 <subsection>
<number>i</number>    any misbranded, adulterated or spurious 
    Ayurvedic, Siddha or Unani drug;
 </subsection><subsection>
<number>ii</number>    any patent or proprietary medicine, 
    unless there is displayed in the prescribed manner on the label or container 
    thereof the true list of all the ingredients contained in it; and
 </subsection><subsection>
<number>iii</number>    any Ayurvedic, Siddha or Unani drug 
    in contravention of any of the provisions of this Chapter or any rule made 
    thereunder;
 </subsection></section><section>
<number>b</number>    sell, stock or exhibit or offer for 
    sale or distribute any Ayurvedic, Siddha or Unani drug which has been 
    manufactured in contravention of any of the provisions of this Act, or any 
    rule made thereunder; 
 </section><section>
<number>c</number>    manufacture for sale or for 
    distribution, any Ayurvedic, Siddha or Unani drug, except under, and in 
    accordance with the conditions of, a licence issued for such purpose under 
    this Chapter by the prescribed authority:
 
Provided 
    that nothing in this section shall apply to Vaidyas and Hakims 
    who manufacture Ayurvedic, Siddha or Unani drug for the use of their own 
    patients:
 
Provided 
    further that nothing in this section shall apply to the manufacture, subject 
    to the prescribed conditions, of small quantities of any Ayurvedic, Siddha 
    or Unani drug for the purpose of examination, test or analysis.]
 




 



</section></article> 
 
 
 
  
 

  
 <article>

<footcitenum>201</footcitenum>[<number>33EED</number> Power of Central Government to prohibit manufacture, etc., of 
    Ayurvedic, Siddha or Unani drugs in public interest.—Without 
    prejudice to any other provision contained in this Chapter, if the Central 
    Government is satisfied on the basis of any evidence or other material 
    available before it that the use of any Ayurvedic, Siddha or Unani drug is 
    likely to involve any risk to human beings or animals or that any such drug 
    does not have the therapeutic value claimed or purported to be claimed for 
    it and that in the public interest it is necessary or expedient so to do 
    then, that Government may, by notification in the Official Gazette, prohibit 
    the manufacture, sale or distribution of such drug.]
 




 



</article> 
 
 
 
  
 

  
 <article>
<number>33F</number> 
    Government Analysts.—
<section><number>1</number> 
    The Central Government or a State Government may, by notification in the 
    Official Gazette, appoint such persons as it thinks fit, having the 
    prescribed qualifications, to be Government Analysts for such areas as may 
    be assigned to them by the Central Government or the State Government, as 
    the case may be.
 </section><section>
<number>2</number> 
    Notwithstanding anything contained in sub-section (1), neither the Central 
    Government nor a State Government shall appoint as a Government Analyst any 
    official not serving under it without the previous consent of the Government 
    under which he is serving.
 


    1[(3) No person who 
    has any financial interest in the manufacture or sale of any drug shall be 
    appointed to be a Government Analyst under this section.] 
 
 
 




 



</section></article> 
 
 
 
  
 

  
 <article>
<number>33G</number> 
    Inspectors.—
<section><number>1</number> 
    The Central Government or a State Government may, by notification in the 
    Official Gazette, appoint such persons as it thinks fit, having the 
    prescribed qualifications, to be Inspectors for such areas as may be 
    assigned to them by the Central Government or the State Government as the 
    case may be.
 </section><section>
<number>2</number> The 
    powers which may be exercised by an Inspector and the duties which may be 
    performed by him and the conditions, limitations or restrictions subject to 
    which such powers and duties may be exercised or performed shall be such as 
    may be prescribed.
 </section><section>
<number>3</number> No 
    person who has any financial interest in the manufacture or sale of any drug 
    shall be appointed to be an Inspector under this section.
 </section><section>
<number>4</number> 
    Every Inspector shall be deemed to be a public servant within the meaning of 
    section 21 of the Indian Penal Code (45 of 1860) and shall be officially 
    subordinate to such authority as the Government appointing him may specify 
    in this behalf.
 


 
  


</section></article> 
 
 
 
  
 

  
 <article>
<number>33H</number> 
    Application of provisions of sections 22, 23, 24 and 25.—The 
    provisions of sections 22, 23, 24 and 25 and the rules, if any, made 
    thereunder shall, so far as may be, apply in relation to an Inspector and a 
    Government Analyst appointed under this Chapter as they apply in relation to 
    an Inspector and a Government Analyst appointed under Chapter IV, subject to 
    the modification that the references to “drug” in the said sections, shall 
    be construed as references to 

    1[Ayurvedic, Siddha or 
    Unani] drug.
 
 




 



</article> 

  
 <article><footcitenum>204</footcitenum>[<footcitenum>205</footcitenum><title>[<number>33-I</number> Penalty for manufacture, sale, etc., 
of Ayurvedic, Siddha or Unani drug in contravention of this Chapter. 
</title>—Whoever himself or by any other person on his behalf— 
 <section><number>1</number> manufactures for sale or for distribution— 
 
 <subsection><footcitenum>206</footcitenum>[<number>a</number> any Ayurvedic, Siddha or Unani drug— 
 
 <subsubsection><number>i</number> deemed to be misbranded under section 33E, 
 </subsubsection><subsubsection><number>ii</number> deemed to be adulterated under section 33EE, or 
 </subsubsection><subsubsection><number>iii</number> without a valid licence or in violation of any of the conditions 
    thereof, as required under section 33EEC, shall be punishable with 
    imprisonment for a term which may extend to one year and with fine which 
    shall not be less than twenty thousand rupees or three times the value of 
    the drugs confiscated, whichever is more;] </subsubsection>
 </subsection><subsection><number>b</number> any Ayurvedic, Siddha or Unani drug deemed to be spurious under section 
  33EEA, shall be punishable with imprisonment for a term which shall not be 
  less than one year but which may extend to three years and with fine which 
  shall not be less than <footcitenum>207</footcitenum>[fifty thousand rupees or three times the 
  value of the drugs confiscated, whichever is more]: </subsection>
 Provided that the Court may, for any adequate and special reasons to be 
mentioned in the judgment, impose a sentence of imprisonment for a term of less 
than one year and of fine of less than <footcitenum>207</footcitenum>[fifty thousand rupees or 
three times the value of the drugs confiscated, whichever is more]; or 
 <subsection><footcitenum>208</footcitenum>[<number>c</number> any Ayurvedic, Siddha or Unani drug in contravention of the 
provisions of any notification issued under section 33EED shall be punishable 
with imprisonment for a term which may extend to three years and with fine which 
may extend to fifty thousand rupees or three times the value of the drugs 
confiscated, whichever is more.] 
 </subsection></section><section><number>2</number> contravenes any other provisions of this Chapter or of section 24 as 
applied by section 33H or any rule made under this Chapter, shall be punishable 
with imprisonment for a term which may extend to <footcitenum>209</footcitenum>[six months and 
with fine which shall not be less than ten thousand rupees]. 










</section></article> 

  
 <article><footcitenum>210</footcitenum>[<footcitenum>211</footcitenum>[<title><number>33J</number> Penalty for subsequent offences. 
</title>—Whoever having been convicted of an offence,— 
 
 <section><number>a</number> under clause (a) of sub-section (1) of section 33-I is again convicted 
  of an offence under that clause, shall be punishable with imprisonment for a 
  term which may extend to two years and with fine which shall not be less than 
  <footcitenum>212</footcitenum>[fifty thousand rupees or three times the value of the drugs 
  confiscated, whichever is more]; 
 </section><section><number>b</number> under clause (b) of sub-section (1) of section 33-I is again convicted 
  of an offence under that clause, shall be punishable with imprisonment for a 
  term which shall not be less than two years but which may extend to six years 
  and with fine which shall not be less than <footcitenum>213</footcitenum>[one lakh rupees or 
  three times the value of the drugs confiscated, whichever is more]: 
 Provided that the Court may, for any adequate and special reasons to be 
  mentioned in the judgment, impose a sentence of imprisonment for a term of 
  less than two years and of fine of less than <footcitenum>213</footcitenum>[one lakh rupees or 
  three times the value of the drugs confiscated, whichever is more]; 
 </section><section><number>c</number> under sub-section (2) of section 33-I is again convicted of an offence 
  under that sub-section, shall be punishable with imprisonment for a term which 
  may extend to <footcitenum>214</footcitenum>[one year and with fine which shall not be less than 
  twenty thousand rupees or three times the value of the drugs confiscated, 
  whichever is more]. </section>





</article> 
 
 
 
  
 

  
 <article>
<number>33K</number> 
    Confiscation.—Where 
    any person has been convicted under this Chapter, the stock of the 


    1[Ayurvedic, Siddha or 
    Unani] drug, in respect of which the contravention has been made, shall be 
    liable to confiscation.
 
 




 



</article> 

  
 <article><footcitenum>216</footcitenum>[<footcitenum>217</footcitenum>[<title><number>33KA</number> Disclosure of name of manufacturer, 
etc. </title>— Every person, not being the manufacturer of any 
Ayurvedic, Siddha or Unani drug or his agent for the distribution thereof, 
shall, if so required, disclose to the Inspector the name, address and other 
particulars of the person from whom he acquired the Ayurvedic, Siddha or Unani 
drug.] 
  


</article> 

  
 <article><footcitenum>218</footcitenum>[<footcitenum>219</footcitenum>[<title><number>33KB</number> Maintenance of records and furnishing 
of information. </title>—Every person holding a licence under clause (c) of 
section 33EEC shall keep and maintain such records, registers and other 
documents as may be prescribed and shall furnish to any officer or authority 
exercising any power or discharging any function under this Act such information 
as is required by such officer or authority for carrying out the purposes of 
this Act.] 


</article> 
 
 
 
  
 

  
 <article>
<number>33L</number> 
    Application of provisions to Government departments.—The 
    provisions of this Chapter except those contained in section 33K shall apply 
    in relation to the manufacture for sale, sale or distribution of any 


    1[Ayurvedic, Siddha or 
    Unani] drug by any department of Government as they apply in relation to the 
    manufacture for sale, sale, or distribution of such drug by any other 
    person.
  



 



</article> 
 
 
 
  
 

  
 <article>
<number>33M</number> 
    Cognizance of offences.—
<section><number>1</number> 
    No prosecution under this Chapter shall be instituted except by an Inspector
    

    1[with the previous 
    sanction of the authority specified under sub-section (4) of section 33G].
 </section><section>
<number>2</number> No 
    Court inferior to that 

    2[of a Metropolitan 
    Magistrate or of a Judicial Magistrate of the first class] shall try an 
    offence punishable under this Chapter.
 
 





 



</section></article> 

  
 <article><title><footcitenum>223</footcitenum>[<number>33N</number> Power of Central Government to make rules. 
</title>—
<section><number>1</number> The Central Government may, <footcitenum>224</footcitenum>[after consultation with, 
or on the recommendation of, the Board] and after previous publication by 
notification in the Official Gazette, make rules for the purpose of giving 
effect to the provisions of this Chapter: 
 Provided that consultation with the Board may be dispensed with if the 
Central Government is of opinion that circumstances have arisen which render it 
necessary to make rules without such consultation, but in such a case, the Board 
shall be consulted within six months of the making of the rules and the Central 
Government shall take into consideration any suggestions which the Board may 
make in relation to the amendment of the said rules. 
 </section><section><number>2</number> Without prejudice to the generality of the foregoing power, such rules 
may— 
 
 <subsection><number>a</number> provide for the establishment of laboratories for testing and analysing 
  <footcitenum>225</footcitenum>[Ayurvedic, Siddha or Unani] drugs; 
 </subsection><subsection><number>b</number> prescribe the qualifications and duties of Government Analysts and the 
  qualifications of Inspectors; 
 </subsection><subsection><number>c</number> prescribe the methods of test or analysis to be employed in determining 
  whether any <footcitenum>225</footcitenum>[Ayurvedic, Siddha or Unani] drug is labelled with the 
  true list of the ingredients which it is purported to contain; 
 </subsection><subsection><number>d</number> specify any substance as a poisonous substance; 
 </subsection><subsection><number>e</number> prescribe the forms of licences for the manufacture for sale of 
  <footcitenum>225</footcitenum>[Ayurvedic, Siddha or Unani] drugs, <footcitenum>226</footcitenum>[and for sale of 
  processed Ayurvedic, Siddha or Unani drugs,] the form of application for such 
  licences, the conditions subject to which such licences may be issued, the 
  authority empowered to issue the same and the fees payable therefor; 
  <footcitenum>226</footcitenum>[and provide for the cancellation or suspension of such licences 
  in any case where any provision of this Chapter or rules made thereunder is 
  contravened or any of the conditions subject to which they are issued is not 
  complied with]; 
 </subsection><subsection><footcitenum>227</footcitenum>[<number>f</number> prescribe the conditions to be observed in the packing of 
  Ayurvedic, Siddha and Unani drugs including the use of packing material which 
  comes into direct contact with the drugs, regulate the mode of labelling 
  packed drugs and prescribe the matters which shall or shall not be included in 
  such labels;] 
 </subsection><subsection><number>g</number> prescribe the conditions subject to which small quantities of 
  <footcitenum>225</footcitenum>[Ayurvedic, Siddha or Unani] drugs may be manufactured for the 
  purpose of examination, test or analysis; and 
 </subsection><subsection><footcitenum>226</footcitenum>[<number>gg</number> prescribe under clause (d) of section 33EE the colour or 
  colours which an Ayurvedic, Siddha or Unani drug may bear or contain for 
  purposes of colouring;] 
 </subsection><subsection><footcitenum>226</footcitenum>[<number>gga</number> prescribe the standards for Ayurvedic, Siddha or Unani 
  drugs under section 33EEB <footcitenum>228</footcitenum>[***];] 
 </subsection><subsection><footcitenum>229</footcitenum>[<number>ggb</number> prescribe the records, registers or other documents to 
  be kept and maintained under section 33KB; and] 
 </subsection><subsection><number>h</number> any other matter which is to be or may be prescribed under this 
  Chapter. </subsection>







</section></article> 
 
 
 
  
 

  
 <article>
<number>33-O</number> 
    Power to amend First Schedule.—The 
    Central Government, after consultation with the Board and after giving, by 
    notification in the Official Gazette, not less than three months’ notice of 
    its intention so to do, may, by a like notification, add to or otherwise 
    amend the First Schedule for the purposes of this Chapter and thereupon the 
    said Schedule shall be deemed to be amended accordingly.]
  

 
  


</article> 
 
 
 
  
 

  
 <article>


    1[2[<number>33P</number>] 
    Power to give directions.—The 
    Central Government may give such directions to any State Government as may 
    appear to the Central Government to be necessary for carrying into execution 
    in the State any of the provisions of this Act or of any rule or order made 
    thereunder.]
 
 





 



</article> 
 
 
 
  
 

  
 <article>
<number>34</number> 
    Offences by companies.—
<section><number>1</number> 
    Where an offence under this Act has been committed by a company, every 
    person who at the time the offence was committed, was in charge of, and was 
    responsible to the company for the conduct of the business of the company, 
    as well as the company shall be deemed to be guilty of the offence and shall 
    be liable to be proceeded against and punished accordingly:
 
Provided 
    that nothing contained in this sub-section shall render any such person 
    liable to any punishment provided in this Act if he proves that the offence 
    was committed without his knowledge or that he exercised all due diligence 
    to prevent the commission of such offence.
 </section><section>
<number>2</number> 
    Notwithstanding anything contained in sub-section (1), where an offence 
    under this Act has been committed by a company and it is proved that the 
    offence has been committed with the consent or connivance of, or is 
    attributable to any neglect on the part of, any director, manager, secretary 
    or other officer of the company, such director, manager, secretary or other 
    officer shall also be deemed to be guilty of that offence and shall be 
    liable to be proceeded against and punished accordingly.
 

    Explanation.—For 
    the purposes of this section—
 <subsection>
<number>a</number>    “company” means a body corporate, and 
    includes a firm or other association of individuals; and
 </subsection><subsection>
<number>b</number>    “director” in relation to a firm means 
    a partner in the firm.
 


 
  


</subsection></section></article> 
 
 
 
  
 

  
 <article>


    1[<number>34A</number> Offences by 
    Government departments.—Where an offence under Chapter IV or Chapter IVA 
    has been committed by any department of Government, such authority as is 
    specified by the Central Government to be in charge of manufacture, sale or 
    distribution of drugs or where no authority is specified, the head of the 
    department, shall be deemed to be guilty of the offence and shall be liable 
    to be proceeded against and punished accordingly: 
 
Provided 
    that nothing contained in this section shall render any such authority or 
    person liable to any punishment provided in Chapter IV or Chapter IVA, as 
    the case may be, if such authority or person proves that the offence was 
    committed without its or his knowledge or that such authority or person 
    exercised all due diligence to prevent the commission of such offence.]
 
 
 




 



</article> 
 
 
 
  
 

  
 <article>


    1[<number>34AA</number> Penalty for 
    vexatious search or seizure.—Any Inspector exercising powers under this 
    Act or the rules made thereunder, who,—
 <section>
<number>a</number>    without reasonable ground of suspicion 
    searches any place, vehicle, vessel or other conveyance; or 
 </section><section>
<number>b</number>    vexatiously and unnecessarily searches 
    any person; or
 </section><section>
<number>c</number>    vexatiously and unnecessarily seizes 
    any drug or cosmetic, or any substance or article, or any record, register, 
    document or other material object; or
 </section><section>
<number>d</number>    commits, as such Inspector, any other 
    act, to the injury of any person without having reason to believe that such 
    act is required for the execution of his duty,
 
shall be punishable with fine which may extend 
    to one thousand rupees.]
 
 




 



</section></article> 
 
 
 
  
 

  
 <article>
<number>35</number> 
    Publication of sentences passed under this Act.—
<section><number>1</number> 
    If any person is convicted of an offence under this Act, 

    1[the Court before 
    which the conviction takes place shall, on application made to it by the 
    Inspector, cause] the offender’s name, place of residence, the offence of 
    which he has been convicted and the penalty which has been inflicted upon 
    him, to be published at the expense of such person in such newspapers or in 
    such other manner as the Court may direct.
 </section><section>
<number>2</number> The 
    expenses of such publication shall be deemed to form part of the costs 
    relating to the conviction and shall be recoverable in the same manner as 
    those costs are recoverable.
 
 




 



</section></article> 
 
 
 
  
 

  
 <article>
<number>36</number> 
    Magistrate’s power to impose enhanced penalties.—Notwithstanding 
    anything contained in 

    1[***] 

    2[the Code of Criminal 
    Procedure, 1973 (2 of 1974)], it shall be lawful for 

    3[any Metropolitan 
    Magistrate or any Judicial Magistrate of the first class] to pass any 
    sentence authorized by this Act in excess of his powers under 

    1[***] the said Code.
 
 






 



</article> 

  
 <article><footcitenum>238</footcitenum>[<footcitenum>239</footcitenum><title>[<number>36A</number> Certain offences to be tried 
summarily. </title>—Notwithstanding anything contained in the Code of Criminal 
Procedure, 1973 (2 of 1974), <footcitenum>240</footcitenum>[all offences(except the offences 
triable by the Special Court under section 36AB or Court of Session) under this 
Act], punishable with imprisonment for a term not exceeding three years, other 
than an offence under clause (b) of sub-section 
<section><number>1</number> of section 33-I, shall be 
tried in a summary way by a Judicial Magistrate of the first class specially 
empowered in this behalf by the State Government or by a Metropolitan Magistrate 
and the provisions of sections 262 to 265 (both inclusive) of the said Code 
shall, as far as may be, apply to such trial: 
 Provided that, in the case of any conviction in a summary trial under this 
section, it shall be lawful for the Magistrate to pass a sentence of 
imprisonment for a term not exceeding one year: 
 Provided further that when at the commencement of, or in the course of, a 
summary trial under this section it appears to the Magistrate that the nature of 
the case is such that a sentence of imprisonment for a term exceeding one year 
may have to be passed or that it is, for any other reason, undesirable to try 
the case summarily, the Magistrate shall, after hearing the parties, record an 
order to that effect and thereafter recall any witness who has been examined and 
proceed to hear or rehear the case in the manner provided by the said Code.] 




</section></article> 

  
 <article><title><footcitenum>241</footcitenum>[<number>36AB</number> Special Courts. </title>— 
<section><number>1</number> The 
Central Government, or the State Government, in consultation with the Chief 
Justice of the High Court, shall, for trial of offences relating to adulterated 
drugs or spurious drugs and punishable under clauses 
<subsection><number>a</number> and (b) of section 13, 
sub-section (3) of section 22, clauses (a) and (c) of section 27, section 28, 
section 28A, section 28B and clause (b) of sub-section (l) of section 30 and 
other offences relating to adulterated drugs or spurious drugs, by notification, 
designate one or more Courts of Session as a Special Court or Special Courts for 
such area or areas or for such case or class or group of cases as may be 
specified in the notification. 
 Explanation .—In this sub-section, “High Court” means the High Court 
of the State in which a Court of Session designated as Special Court was 
functioning immediately before such designation. 
 </subsection></section><section><number>2</number> While trying an offence under this Act, a Special Court shall also try an 
offence, other than an offence referred to in sub-section (l), with which the 
accused may, under the Code of Criminal Procedure, 1973 (2 of 1974), be charged 
at the same trial.] 


</section></article> 

  
 <article><footcitenum>242</footcitenum>[<footcitenum>243</footcitenum><title>[<number>36AC</number> Offences to be cognizable and 
non-bailable in certain cases. </title>— 
<section><number>1</number> Notwithstanding anything 
contained in the Code of Criminal Procedure, 1973 (2 of 1974),— 
 
 <subsection><number>a</number> every offence, relating to adulterated or spurious drug and punishable 
  under clauses (a) and (c) of sub-section (1) of section 13, clause (a) of 
  sub-section (2) of section 13, sub-section (3) of section 22, clauses (a) and 
  (c) of section 27, section 28, section 28A, section 28B and sub-sections (1) 
  and (2) of section 30 and other offences relating to adulterated drugs or 
  spurious drugs, shall be cognizable. 
 </subsection><subsection><number>b</number> no person accused, of an offence punishable under clauses (a) and 
   (c) of sub-section (1) of section 13, clause (a) of sub-section (2) of 
  section 13, sub-section (3) of section 22, clauses (a) and (c) of section 27, 
  section 28, section 28A, section 28B and sub-sections (1) and (2) of section 
  30 and other offences relating to adulterated drugs or spurious drugs, shall 
  be released on bail or on his own bond unless— 
 
 <subsubsection><number>i</number> the Public Prosecutor has been given an opportunity to oppose the 
    application for such release; and 
 </subsubsection><subsubsection><number>ii</number> where the Public Prosecutor opposes the application, the Court is 
    satisfied that there are reasonable grounds for believing that he is not 
    guilty of such offence and that he is not likely to commit any offence while 
    on bail: </subsubsection>
 Provided that a person, who, is under the age of sixteen years, or is a 
  woman or is sick or infirm, may be released on bail, if the Special Court so 
  directs. </subsection>
 </section><section><number>2</number> The limitation on granting of bail specified in clause (b) of sub-section 
(1) is in addition to the limitations under the Code of Criminal Procedure, 1973 
(2 of 1974) or any other law for the time being in force on granting of bail. 

 </section><section><number>3</number> Nothing contained in this section shall be deemed to affect the special 
powers of the High Court regarding bail under section 439 of the Code of 
Criminal Procedure, 1973 (2 of 1974) and the High Court may exercise such powers 
including the power under clause (b) of sub-section (1) of that section as if 
the reference to “Magistrate” in that section includes also a reference to a 
“Special Court” designated under section 36AB.] 


</section></article> 

  
 <article><footcitenum>244</footcitenum>[<footcitenum>245</footcitenum><title>[</title><title><number>36AD</number> Application of Code 
of Criminal Procedure, 1973 to proceedings before Special Court. </title>— 

<section><number>1</number> Save as otherwise provided in this Act, the provisions of the Code of 
Criminal Procedure, 1973 (2 of 1974) (including the provisions as to bails or 
bonds), shall apply to the proceedings before a Special Court and for the 
purposes of the said provisions, the Special Court shall be deemed to be a Court 
of Session and the person conducting the prosecution before the Special Court, 
shall be deemed to be a Public Prosecutor: 
 Provided that the Central Government or the State Government may also 
appoint, for any case or class or group of cases, a Special Public Prosecutor. 

 </section><section><number>2</number> A person shall not be qualified to be appointed as a Public Prosecutor or 
a Special Public Prosecutor under this section unless he has been in practice as 
an advocate for not less than seven years, under the Union or a State, requiring 
special knowledge of law. 
 </section><section><number>3</number> Every person appointed as a Public Prosecutor or a Special Public 
Prosecutor under this section shall be deemed to be a Public Prosecutor within 
the meaning of clause (u) of section 2 of the Code of Criminal Procedure, 1973 
(2 of 1974) and the provisions of that Code shall have effect accordingly.] 


</section></article> 

  
 <article><footcitenum>246</footcitenum>[<footcitenum>247</footcitenum>[<title><number>36AE</number> Appeal and revision. </title>—The 
High Court may exercise, so far as may be applicable, all the powers conferred 
by Chapter XXIX or Chapter XXX of the Code of Criminal Procedure, l973 (2 of 
1974), on a High Court, as if a Special Court within the local limits of the 
jurisdiction of the High Court were a Court of Session trying cases within the 
local limits of the jurisdiction of the High Court.] ] 


</article> 
 
 
 
  
 

  
 <article>
<number>37</number> 
    Protection of action taken in good faith.—No 
    suit, prosecution or other legal proceeding shall lie against any person for 
    anything which is in good faith done or intended to be done under this Act.
 

 
  


</article> 
 
 
 
  
 

  
 <article>


    1[<number>38</number> Rules to be 
    laid before Parliament.—Every rule made under this Act shall be laid as 
    soon as may be after it is made before each House of Parliament while it is 
    in session for a total period of thirty days which may be comprised in one 
    session or in two or more successive sessions, 

    2[and if, before the 
    expiry of the session immediately following the session or the successive 
    sessions aforesaid], both Houses agree in making any modification in the 
    rule or both Houses agree that the rule should not be made, the rule shall 
    thereafter have effect only in such modified form or be of no effect, as the 
    case may be; so however that any such modification or annulment shall be 
    without prejudice to the validity of anything previously done under that 
    rule.]
 
 





 



</article>
<pagefootnote>
<pagenote><number>1</number> Ins. by Act 13 of 1964, sec. 2 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>2</number> Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) or Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>3</number> Subs. by Act 68 of 1982, sec. 3, for “disease in human beings, mentioned in, and processed and manufactured” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>4</number> Subs. by Act 68 of 1982, sec. 3, for “Ayurvedic (including Siddha) and Unani (Tibb) system of medicine” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>5</number> Original clause (a) relettered as clause (aa) and subs. by Act 13 of 1964, sec. 2 (w.e.f. 
  15-9-1964).</pagenote>

<pagenote><number>6</number> Subs. by Act 68 of 1982, sec. 3, for “Ayurvedic and Unani Drugs Technical Advisory Board” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>7</number> Clause (aa) ins. by Act 21 of 1962, sec. 4 (w.e.f. 27-7-1964) and relettered as clause (aaa) by Act 13 of 1964, sec. 2 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>8</number> The words “, but does not include soap” omitted by Act 68 of 1982, sec. 3 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>9</number> Subs. by Act 11 of 1955, sec. 2, for clause (b) (w.e.f. 15-4-1955).</pagenote>

<pagenote><number>10</number> Subs. by Act 68 of 1982, sec. 3, for sub-clause (i) (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>11</number> Subs. by Act 13 of 1964, sec. 2, for “vermins” (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>12</number> Ins. by Act 68 of 1982, sec. 3 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>13</number> Subs. by Act 13 of 1964, sec. 2, for clause (c) (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>14</number> Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) or Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>15</number> Clause (d) omitted by Act 19 of 1972, sec. 3 (w.e.f. 31-5-1972).</pagenote>

<pagenote><number>16</number> Subs. by Act 13 of 1964, sec. 2, for clause (e) (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>17</number> Clause (bbb) ins. by Act 11 of 1955, sec. 2 (w.e.f. 15-4-1955) and relettered as clause (f) by Act 35 of 1960, sec. 2 (w.e.f. 16-3-1961)</pagenote>

<pagenote><number>18</number> Ins. by Act 21 of 1962, sec. 4 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>19</number> Subs. by Act 68 of 1982, sec. 3, for “sale and distribution” (w.e.f. 1-2-1983)</pagenote>

<pagenote><number>20</number> Subs. by Act 21 of 1962, sec. 4, for “or packing of any drug”.</pagenote>

<pagenote><number>21</number> Clauses (c), (d) and (e) relettered as clauses (g), (h) and (i) respectively by Act 35 of 1960, sec. 2 (w.e.f. 16-3-1961).</pagenote>

<pagenote><number>22</number> Subs. by Act 3 of 1951, sec. 3 and Sch., for “the States”.</pagenote>

<pagenote><number>23</number> Clause (d) relettered as clause (h) by Act 35 of 1960, sec. 2 (w.e.f. 16-3-1961) and subs. by Act 68 of 1982, sec. 3 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>24</number> Clause (e) subs. by Act 11 of 1955, sec. 2 (w.e.f. 15-4-1955) and relettered as clause (i) by Act 35 of 1960, sec. 2 (w.e.f. 16-3-1961).</pagenote>

<pagenote><number>25</number> Clause (f) ins. by the A.O. 1950 and omitted by Act 3 of 1951, sec. 3 and Sch.</pagenote>

<pagenote><number>26</number>   Ins. by Act 19 of 
    1972, sec. 4 (w.e.f. 31-5-1972).</pagenote>

<pagenote><number>27</number>   Ins. by Act 13 of 
    1964, sec. 3 (w.e.f. 15-9-1964).  tc 
    "  1. Ins. by 
    Act 13 of 1964, sec. 3 (w.e.f. 15-9-1964)."</pagenote>

<pagenote><number>28</number>   Subs. by Act 13 of 
    1964, sec. 4, for sub-section (2) (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>29</number>   Subs. by Act 13 of 
    1964, sec. 4, for the Proviso (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>30</number>   Ins. by Act 21 of 
    1962, sec. 5 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>31</number>   Clauses (b) and (c) 
    omitted by Act 11 of 1955, sec. 4 (w.e.f. 15-4-1955).</pagenote>

<pagenote><number>32</number>   Subs. by Act 13 of 
    1964, sec. 5, for “under Chapter IV” (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>33</number>   Ins. by Act 3 of 1951, 
    sec. 3 and Sch., for “the States”.</pagenote>

<pagenote><number>34</number>   Ins. by Act 13 of 
    1964, sec. 6 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>35</number>   Subs. by Act 68 of 
    1982, sec. 2, for “Ayurvedic (including Siddha) or Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>36</number>   Subs. by Act 21 of 
    1962, sec. 6, for sub-section (1) (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>37</number>   Subs. by Act 13 of 
    1964, sec. 7, for “the Schedule” (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>38</number>   Subs. by Act 68 of 
    1982, sec. 5, for section 9 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>39</number>   Section 9A ins. by Act 
    21 of 1962, sec. 7 and subs. by Act 68 of 1982, sec. 6 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>40</number>   Section 9B ins. by Act 
    13 of 1964, sec. 8 (w.e.f. 15-9-1964) and subs. by Act 68 of 1982, sec. 6 (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>41</number>   Ins. by Act 68 of 
    1982, sec. 6 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>42</number>   Ins. by Act 68 of 
    1982, sec. 6 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>43</number>   Ins. by Act 68 of 
    1982, sec. 8 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>44</number>   Now see the Customs 
    Act, 1962 (52 of 1962).</pagenote>

<pagenote><number>45</number>   Ins. by Act 21 of 1962, 
    sec. 9 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>46</number>   Subs. by Act 22 of 1995, 
    sec. 83, for “Customs Collector” (w.e.f. 26-5-1995).</pagenote>

<pagenote><number>47</number>   Ins. by Act 21 of 1962, 
    sec. 9 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>48</number>   Subs. by Act 11 of 1955, 
    sec. 6, for  sub-section (2) (w.e.f. 15-4-1955).</pagenote>

<pagenote><number>49</number>   Subs. by Act 22 of 1995, 
    sec. 83, for “Customs Collector” (w.e.f. 26-5-1995).</pagenote>

<pagenote><number>50</number>   Ins. by Act 21 of 1962, 
    sec. 9 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>51</number>   Subs. by Act 68 of 1982, sec. 9, for “after consultation with the 
    Board” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>52</number>   Ins. by Act 11 of 1955, sec. 7 (w.e.f. 15-4-1955).</pagenote>

<pagenote><number>53</number>   Ins. by Act 21 of 1962, sec. 10 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>54</number>   Subs. by Act 68 of 1982, sec. 9, for certain words (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>55</number>   Ins. by Act 13 of 1964, sec. 10 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>56</number>   Subs. by Act 68 of 1982, sec. 9 for “section 9B” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>57</number>   Subs. by Act 11 of 1955, sec. 7, for “to cure or mitigate” (w.e.f. 
    15-4-1955).</pagenote>

<pagenote><number>58</number>   Ins. by Act 21 of 1962, sec. 10 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>59</number>   Subs. by Act 3 of 1951, sec. 3 and Sch., for “the States”.</pagenote>

<pagenote><number>60</number>   Ins. by Act 68 of 1982, sec. 9 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>61</number>   Ins. by Act 21 of 1962, sec. 10 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>62</number>   Subs. by Act 68 of 1982, sec. 10, for section 13 (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>63</number>   Ins. by Act 21 of 1962, sec. 11 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>64</number>   Subs. by Act 68 of 1982, sec. 11, for certain words (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>65</number>   Subs. by Act 21 of 1962, sec. 12, for sub-section (1) (w.e.f. 
    27-7-1964).</pagenote>

<pagenote><number>66</number>   Subs. by Act 13 of 1964, sec. 11, for “the Schedule” (w.e.f. 
    15-9-1964).</pagenote>

<pagenote><number>67</number>   Subs. by Act 11 of 1955, sec. 8, for “State Government” (w.e.f. 
    15-4-1955).</pagenote>

<pagenote><number>68</number>   Subs. by Act 68 of 1982, sec. 13, for section 17 (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>69</number>   Section 17A ins. by Act 21 of 1962, sec. 13 (w.e.f. 27-7-1963) and 
    subs. by Act 68 of 1982, sec. 13 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>70</number>   Section 17B ins. by Act 13 of 1964, sec. 12 (w.e.f. 15-9-1964) and 
    subs. by Act 68 of 1982, sec. 13 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>71</number>   Ins. by Act 68 of 1982, sec. 13 (w.e.f. 1-2-1983).   tc 
    "  
    2. Ins. by Act 68 of 1982, sec. 13 (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>72</number>   Ins. by Act 68 of 1982, sec. 13 (w.e.f. 1-2-1983).   tc 
    "  
    2. Ins. by Act 68 of 1982, sec. 13 (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>73</number> Ins. by Act 26 of 2008, sec. 2.</pagenote>

<pagenote><number>74</number> 1st April, 1947, for sub-clauses (i), (ii), (iv) and (v) of clause (a) and clauses (b) and (c); 1st April, 1949 for sub-clause (iii) of clause (a) in so far as it takes effect in Delhi, Ajmer and Coorg,  see   Notification No. 18-12-46-D, II, dated 11th February, 1947, Gazette of India, 1947, Pt. I, p. 189, as amended by Notification No. F.1-2/48-D(II), dated 29th September, 1948; 1st April, 1953 for the States of Himachal Pradesh, Bilaspur, Kutch, Bhopal , Tripura, Vindhya Pradesh and Manipur,  vide   Notification No. S.R.O. 664, dated 30th March, 1953, Gazette of India, 1953, Pt. II, Sec. 3, p. 451.</pagenote>

<pagenote><number>75</number> Subs. by Act 68 of 1982, sec. 14, for “manufacture for sale, or sell, or stock or exhibit for sale” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>76</number> Subs. by Act 68 of 1982, sec. 14, for clauses (i), (ii) and (iia) (w.e.f. 1-2-1983). Earlier clauses (i) and (ii) were amended by Act 21 of 1962, sec. 14 (w.e.f. 27-7-1964) and clause (iia) was inserted by Act 13 of 1964, sec. 13 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>77</number> Subs. by Act 26 of 2008, sec. 3, for sub-clause (ii). Sub-clause (ii), before substitution, stood as under:</pagenote>

<pagenote><number>78</number> Subs. by Act 11 of 1955, sec. 9, for sub-clause (iii).</pagenote>

<pagenote><number>79</number> Subs. by Act 68 of 1982, sec. 14, for certain words (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>80</number> Subs. by Act 11 of 1955, sec. 9, for “to cure or mitigate”.</pagenote>

<pagenote><number>81</number> Subs. by Act 21 of 1962, sec. 14, for sub-clause (v) (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>82</number> Subs. by Act 68 of 1982, sec. 14, for “sell, or stock or exhibit for sale”.</pagenote>

<pagenote><number>83</number> Ins. by Act 21 of 1962, sec. 14 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>84</number> Subs. by Act 68 of 1982, sec. 14, for certain words (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>85</number> Subs. by Act 11 of 1955, sec. 9, for “State Government”.</pagenote>

<pagenote><number>86</number> Subs. by Act 68 of 1982, sec. 14, for “manufacture for sale, sale” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>87</number>  Explanation  omitted by Act 68 of 1982, sec. 14 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>88</number>   Ins. by Act 13 of 1964, sec. 14 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>89</number>   Ins. by Act 68 of 1982, sec. 15 (w.e.f 1-2-1983).</pagenote>

<pagenote><number>90</number>   Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964).   tc 
    "  
    6. Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964)."</pagenote>

<pagenote><number>91</number>   Subs. by Act 13 of 1964, sec. 15, for certain words (w.e.f. 15-9-1964).   tc 
    "  
    1. Subs. by Act 13 of 1964, sec. 15, for certain words (w.e.f. 15-9-1964)."</pagenote>

<pagenote><number>92</number>   Subs. by Act 68 of 1982, sec. 16, for “adulterated” (w.e.f. 1-2-1983).   tc 
    "  
    2. Subs. by Act 68 of 1982, sec. 16, for “adulterated” (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>93</number>   Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964).   tc 
    "  
    3. Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964)."</pagenote>

<pagenote><number>94</number>   Clause (aa) ins. by Act 11 of 1955, sec. 10 (w.e.f. 15-4-1955) and 
    omitted by Act 13 of 1964, sec. 15 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>95</number>   Subs. by Act 13 of 1964, sec. 15, for sub-section (3) (w.e.f. 
    15-9-1964).   tc 
    "  
    5. Subs. by Act 13 of 1964, sec. 15, for sub-section (3) (w.e.f. 
    15-9-1964)."</pagenote>

<pagenote><number>96</number>   Subs. by Act 35 of 1960, sec. 4, for section 20 (w.e.f. 
    16-3-1961).</pagenote>

<pagenote><number>97</number>   Subs. by Act 21 of 1962, sec. 16, for “class of drugs” (w.e.f. 
    27-7-1964).</pagenote>

<pagenote><number>98</number>   Ins. by Act 68 of 1982, sec. 17 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>99</number>   Subs. by Act 35 of 1960, sec. 4, for section 21 (w.e.f. 16-3-1961).   tc 
    "  
    3. Subs. by Act 35 of 1960, sec. 4, for section 21 (w.e.f. 16-3-1961)."</pagenote>

<pagenote><number>100</number>   Subs. by Act 21 of 1962, sec. 17 for “class of drugs” (w.e.f. 
    27-7-1964).</pagenote>

<pagenote><number>101</number>   Subs. by Act 21 of 1962, sec. 17, for “in the manufacture, import or 
    sale of drugs” (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>102</number>   Ins. by Act 68 of 1982, sec. 18 (w.e.f. 1-2-1983).   tc 
    "  
    6. Ins. by Act 68 of 1982, sec. 18 (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>103</number>   Subs. by Act 11 of 1955, sec. 11, for section 22 (w.e.f. 15-4-1955).   tc 
    "  
    7. Subs. by Act 11 of 1955, sec. 11, for section 22 (w.e.f. 15-4-1955)."</pagenote>

<pagenote><number>104</number>   Subs. by Act 68 of 1982, sec. 19, for clauses (a), (b) and (c) (w.e.f. 
    1-2-1983).   tc 
    "  
    1. Subs. by Act 68 of 1982, sec. 19, for clauses (a), (b) and (c) (w.e.f. 
    1-2-1983)."</pagenote>

<pagenote><number>105</number>   Ins. by Act 35 of 1960, sec. 5 (w.e.f. 16-3-1961).   tc 
    "  
    2. Ins. by Act 35 of 1960, sec. 5 (w.e.f. 16-3-1961)."</pagenote>

<pagenote><number>106</number>   Subs. by Act 68 of 1982, sec. 19, for “in any place mentioned in clause 
    (c)” (w.e.f. 1-2-1983).   tc 
    "  
    3. Subs. by Act 68 of 1982, sec. 19, for “in any place mentioned in clause 
    (c)” (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>107</number>   Ins. by Act 68 of 1982, sec. 19 (w.e.f. 1-2-1983).   tc 
    "  
    4. Ins. by Act 68 of 1982, sec. 19 (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>108</number>   Subs. by Act 68 of 1982, sec. 19, for “the Code of Criminal Procedure, 
    1898 (5 of 1898)” (w.e.f. 1-2-1983).   tc 
    "  
    1. Subs. by Act 68 of 1982, sec. 19, for “the Code of Criminal Procedure, 
    1898 (5 of 1898)” (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>109</number>   Subs. by Act 68 of 1982, sec. 19, for “section 98” (w.e.f. 1-2-1983).   tc 
    "  
    2. Subs. by Act 68 of 1982, sec. 19, for “section 98” (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>110</number>   Ins. by Act 68 of 1982, sec. 19 (w.e.f. 1-2-1983).   tc 
    "  
    3. Ins. by Act 68 of 1982, sec. 19 (w.e.f. 1-2-1983)."</pagenote>

<pagenote><number>111</number>   Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>112</number>   Subs. by Act 13 of 1964, sec. 16, for clause (iii) (w.e.f. 15-9-1964).   t</pagenote>

<pagenote><number>113</number>   Subs. by Act 68 of 1982, sec. 20, for “a Magistrate” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>114</number>   Ins. by Act 35 of 1960, sec. 6 (w.e.f. 16-3-1961).</pagenote>

<pagenote><number>115</number>   Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>116</number> Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964 ).</pagenote>

<pagenote><number>117</number> Subs. by Act 13 of 1964, sec. 17, for certain words (w.e.f. 
15-9-1964 ).</pagenote>

<pagenote><number>118</number> Subs. by Act 13 of 1964, sec. 17, for “or the said warrantor” 
(w.e.f. 15-9-1964 ).</pagenote>

<pagenote><number>119</number>   Ins. by Act 71 of 1986, sec. 2 (w.e.f. 15-9-1987).   tc 
    "  
    1. Ins. by Act 71 of 1986, sec. 2 (w.e.f. 15-9-1987)."</pagenote>

<pagenote><number>120</number>   Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964).   tc 
    "  
    2. Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964)."</pagenote>

<pagenote><number>121</number>   Subs. by Act 71 of 1986, sec. 2, for “purchased by him” (w.e.f. 
    15-9-1987).   tc 
    "  
    3. Subs. by Act 71 of 1986, sec. 2, for “purchased by him” (w.e.f. 
    15-9-1987)."</pagenote>

<pagenote><number>122</number>   Added by Act 71 of 1986, sec. 2 (w.e.f. 15-9-1987).   tc 
    "  
    4. Added by Act 71 of 1986, sec. 2 (w.e.f. 15-9-1987)."</pagenote>

<pagenote><number>123</number> Ins. by Act 68 of 1982, sec. 21 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>124</number> Subs. by Act 26 of 2008, sec. 4, for “prohibit”.</pagenote>

<pagenote><number>125</number> Ins. by Act 26 of 2008, sec. 5.</pagenote>

<pagenote><number>126</number> Subs. by Act 68 of 1982, sec. 22, for section 27 (w.e.f. 
1-12-1983). Earlier section 27 was substituted by Act 13 of 1964, sec. 18 
(w.e.f. 15-9-1964).</pagenote>

<pagenote><number>127</number> Subs. by Act 26 of 2008, sec. 6(i)(A), for “17B or which”.</pagenote>

<pagenote><number>128</number> Subs. by Act 26 of 2008, sec. 6(i)(B), for “punishable with 
imprisonment for a term which shall not be less than five years but which may 
extend to a term of life and with fine which shall not be less than ten thousand 
rupees;”</pagenote>

<pagenote><number>129</number> Ins. by Act 26 of 2008, sec. 6(i)(C).</pagenote>

<pagenote><number>130</number> Subs. by Act 26 of 2008, sec. 6(ii)(A), for “not be less than 
one year but which may extend to three years and with fine which shall not be 
less than five thousand rupees”.</pagenote>

<pagenote><number>131</number> Subs. by Act 26 of 2008, sec. 6(ii)(B), for “less than one 
year and of fine of less than five thousand rupees”.</pagenote>

<pagenote><number>132</number> Subs. by Act 26 of 2008, sec. 6(iii)(A), for “not be less 
than three years but which may extend to five years and with fine which shall 
not be less than five thousand rupees”.</pagenote>

<pagenote><number>133</number> Subs. by Act 26 of 2008, sec. 6(iii)(B), for “less than three 
years but not less than one year”.</pagenote>

<pagenote><number>134</number> Subs. by Act 26 of 2008, sec. 6(iv), for “and with 
fine”.</pagenote>

<pagenote><number>135</number> Subs. by Act 68 of 1982, sec. 22, for section 27A (w.e.f. 
1-2-1983). Earlier section 27A was inserted by Act 21 of 1962, sec. 19 (w.e.f. 
27-7-1964).</pagenote>

<pagenote><number>136</number> Subs. by Act 26 of 2008, sec. 7, for clauses (i) and (ii). 
Clauses (i) and (ii), before substitution, stood as under:</pagenote>

<pagenote><number>137</number> Subs. by Act 13 of 1964, sec. 19, for section 28 (w.e.f. 
15-9-1964).</pagenote>

<pagenote><number>138</number> Ins. by Act 68 of 1982, sec. 23 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>139</number> Subs. by Act 26 of 2008, sec. 8, for “with fine which may 
extend to one thousand rupees, or with both”. Earlier the said words were 
amended by Act 68 of 1982, sec. 23 (w.e.f.</pagenote>

<pagenote><number>140</number> Ins. by Act 68 of 1982, sec. 24 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>141</number> Subs. by Act 26 of 2008, sec. 9, for “with fine which may 
extend to one thousand rupees or with both”.</pagenote>

<pagenote><number>142</number>   Ins. by Act 68 of 1982, sec. 24 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>143</number> Ins. by Act 21 of 1962, sec. 15 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>144</number> Subs. by Act 26 of 2008, sec. 10, for “five hundred rupees”.</pagenote>

<pagenote><number>145</number> Subs. by Act 11 of 1955, sec. 14, for section 30 (w.e.f. 
15-4-1955).</pagenote>

<pagenote><number>146</number> Subs. by Act 68 of 1982, sec. 25, for sub-section (1) (w.e.f. 
1-2-1983).</pagenote>

<pagenote><number>147</number> Subs. by Act 26 of 2008, sec. 11(a)(i)(A), for “not be less 
than two years but which may extend to six years and with fine which shall not 
be less than ten thousand rupees”.</pagenote>

<pagenote><number>148</number> Subs. by Act 26 of 2008, sec. 11(a)(i)(B), for “less than two 
years and of fine of less than ten thousand rupees;”.</pagenote>

<pagenote><number>149</number> Subs. by Act 26 of 2008, sec. 11(a)(ii), for “shall not be 
less than six years but which may extend to ten years and with fine which shall 
not be less than ten thousand rupees;”</pagenote>

<pagenote><number>150</number> Subs. by Act 26 of 2008, sec. 11(a)(iii), for “five thousand 
rupees”.</pagenote>

<pagenote><number>151</number> Ins. by Act 21 of 1962, sec. 20 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>152</number> Subs. by Act 68 of 1982, sec. 25, for “one thousand rupees” 
(w.e.f. 1-2-1983).</pagenote>

<pagenote><number>153</number> The words “section 28 or” omitted by Act 13 of 1964, sec. 20 
(w.e.f. 15-9-1964).</pagenote>

<pagenote><number>154</number> Subs. by Act 26 of 2008, sec. 11(b), for “ten years, or with 
fine, or with both”.</pagenote>

<pagenote><number>155</number>   Section 31 re-numbered as sub-section (1) of that section by Act 35 of 
    1960, sec. 9 (w.e.f. 16-3-1961).</pagenote>

<pagenote><number>156</number>   Ins. by Act 21 of 1962, sec. 21 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>157</number>   Added by Act 13 of 1964, sec. 21 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>158</number>   Subs. by Act 68 of 1982, sec. 26, for clause (i) (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>159</number>   Subs. by Act 68 of 1982, sec. 26, for certain words (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>160</number>   Sub-section (2) ins. by Act 35 of 1960, sec. 9 (w.e.f. 16-3-1961) and 
    subs. by Act 21 of 1962, sec. 21 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>161</number>   Subs. by Act 13 of 1964, sec. 21, for “or is a misbranded drug” (w.e.f. 
    15-9-1964).</pagenote>

<pagenote><number>162</number>   Subs. by Act 68 of 1982, sec. 26, for “misbranded or adulterated drug, 
    or misbranded cosmetic” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>163</number>   Ins. by Act 13 of 1964, sec. 22 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>164</number> Subs. by Act 26 of 2008, sec. 12, for sub-sections (1) and 
(2). Sub-sections (1) and (2), before substitution, stood as under:</pagenote>

<pagenote><number>165</number>   Ins. by Act 13 of 1964, sec. 23 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>166</number>   Subs. by Act 68 of 1982, sec. 28, for “in sub-section (1) of section 
    351 of the Code of Criminal Procedure, 1898 (5 of 1898)” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>167</number> Ins. by Act 26 of 2008, sec. 13.</pagenote>

<pagenote><number>168</number> Subs. by Act 11 of 1955, sec. 15, for sub-section (1) (w.e.f. 
15-4-1955).</pagenote>

<pagenote><number>169</number> Subs. by Act 68 of 1982, sec. 29, for “after consultation 
with the Board” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>170</number> Ins. by Act 21 of 1962, sec. 22 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>171</number> Ins. by Act 13 of 1964, sec. 24 (w.e.f. 15-9-1964).</pagenote>

<pagenote><number>172</number> Subs. by Act 68 of 1982, sec. 29, for “section 17B” (w.e.f. 
1-2-1983).</pagenote>

<pagenote><number>173</number> Ins. by Act 26 of 2008, sec. 14(i).</pagenote>

<pagenote><number>174</number> Subs. by Act 68 of 1982, sec. 29, for “for the manufacture 
for sale” (w.e.f. 1-2-1983)</pagenote>

<pagenote><number>175</number> Ins. by Act 21 of 1962, sec. 22 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>176</number> Ins. by Act 68 of 1982, sec. 29 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>177</number> Subs. by Act 11 of 1955, sec. 15, for “to cure or mitigate” 
(w.e.f. 15-4-1955).</pagenote>

<pagenote><number>178</number> Clause (m) omitted by Act 13 of 1964, sec. 24 (w.e.f. 
15-9-1964).</pagenote>

<pagenote><number>179</number> Subs. by Act 35 of 1960, sec. 10, for clause (n) (w.e.f. 
16-3-1961).</pagenote>

<pagenote><number>180</number> Ins. by Act 68 of 1982, sec. 29 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>181</number> Subs. by Act 21 of 1962, sec. 22, for “the drugs or class of 
drugs” (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>182</number> Subs. by Act 13 of 1964, sec. 24, for clause (p) (w.e.f. 
15-9-1964).</pagenote>

<pagenote><number>183</number> The word “and” omitted by Act 26 of 2008, sec. 14(ii).</pagenote>

<pagenote><number>184</number> Ins. by Act 21 of 1962, sec. 22 (w.e.f. 27-7-1964).</pagenote>

<pagenote><number>185</number> Ins. by Act 26 of 2008, sec. 14(iii).</pagenote>

<pagenote><number>186</number> Ins. by Act 26 of 2008, sec. 14(iv).</pagenote>

<pagenote><number>187</number> Sub-section (3) omitted by Act 13 of 1964, sec. 24 (w.e.f. 
15-9-1964). Earlier sub-section (3) was inserted by Act 35 of 1960, sec. 10 
(w.e.f. 16-3-1961).</pagenote>

<pagenote><number>188</number>   Ins. by Act 13 of 1964, sec. 25 (w.e.f. 1-2-1969).</pagenote>

<pagenote><number>189</number>   Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) or 
    Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>190</number>   Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) 
    and Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>191</number>   Subs. by Act 68 of 1982, sec. 30, for “Ayurvedic and Unani Drugs 
    Technical Adviory Board” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>192</number>   Subs. by Act 68 of 1982, sec. 30, for clause (iii) (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>193</number>   Subs. by Act 68 of 1982, sec. 30, for clause (viii) (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>194</number>   Subs. by Act 68 of 1982, sec. 30, for clauses (xi) and (xii) (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>195</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>196</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>197</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>198</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>199</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>200</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>201</number>   Subs. by Act 68 of 1982, sec. 31, for sections 33D and 33E (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>202</number>   Ins. by Act 68 of 1982, sec. 32 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>203</number>   Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) or 
    Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>204</number> Section 33I ins. by Act 13 of 1964, sec. 26 (w.e.f. 
1-2-1969).</pagenote>

<pagenote><number>205</number> Subs. by Act 68 of 1982, sec. 33, for section 33-I (w.e.f. 
1-2-1983).</pagenote>

<pagenote><number>206</number> Subs. by Act 26 of 2008, sec. 15(a)(i), for clause (a). 
Clause (a), before substitution, stood as under:</pagenote>

<pagenote><number>207</number> Subs. by Act 26 of 2008, sec. 15(a)(ii), for “five thousand 
rupees”.</pagenote>

<pagenote><number>208</number> Ins. by Act 26 of 2008, sec. 15(a)(iii).</pagenote>

<pagenote><number>209</number> Subs. by Act 26 of 2008, sec. 15(b), for “three months and 
with fine which shall not be less than five hundred rupees.”.</pagenote>

<pagenote><number>210</number>Section 33J ins. by Act 13 of 1964, sec. 26 (w.e.f. 
1-2-1969).</pagenote>

<pagenote><number>211</number> Subs. by Act 68 of 1982, sec. 33, for section 33J (w.e.f. 
1-2-1983).</pagenote>

<pagenote><number>212</number> Subs. by Act 26 of 2008, sec. 16(a), for “two thousand 
rupees”.</pagenote>

<pagenote><number>213</number> Subs. by Act 26 of 2008, sec. 16(b), for “five thousand 
rupees”.</pagenote>

<pagenote><number>214</number> Subs. by Act 26 of 2008, sec. 16(c), for “six months and with 
fine which shall not be less than one thousand rupees.”.</pagenote>

<pagenote><number>215</number>   Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) or 
    Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>216</number>Section 33KA ins. by Act 13 of 1964, sec. 26 (w.e.f. 
1-2-1969).</pagenote>

<pagenote><number>217</number> Ins. by Act 26 of 2008, sec. 17.</pagenote>

<pagenote><number>218</number>Section 33KB ins. by Act 13 of 1964, sec. 26 (w.e.f. 
1-2-1969).</pagenote>

<pagenote><number>219</number> Ins. by Act 26 of 2008, sec. 17.</pagenote>

<pagenote><number>220</number>   Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including Siddha) or 
    Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>221</number>   Ins. by Act 68 of 1982, sec. 34 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>222</number>   Subs.  by  Act  68  of  1982, sec. 34, for “of a Presidency 
    Magistrate or of a Magistrate of the first class” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>223</number>Section 33N ins. by Act 13 of 1964, sec. 26 (w.e.f. 
1-2-1969).</pagenote>

<pagenote><number>224</number> Subs. by Act 68 of 1982, sec. 35, for “after consultation 
with the Board” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>225</number> Subs. by Act 68 of 1982, sec. 2, for “Ayurvedic (including 
Siddha) or Unani” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>226</number> Ins. by Act 68 of 1982, sec. 35 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>227</number> Subs. by Act 68 of 1982, sec. 35, for clause (f) (w.e.f. 
1-2-1983).</pagenote>

<pagenote><number>228</number> The word “and” omitted by Act 26 of 2008, sec. 18(i).</pagenote>

<pagenote><number>229</number> Ins. by Act 26 of 2008, sec. 18(ii).</pagenote>

<pagenote><number>230</number>   Ins. by Act 35 of 1960, sec. 11 (w.e.f. 16-3-1961).</pagenote>

<pagenote><number>231</number>   Section 33A re-numbered as section 33P by Act 13 of 1964, sec. 27 (w.e.f. 
    15-9-1964).</pagenote>

<pagenote><number>232</number>   Ins. by Act 13 of 1964, sec. 28 (w.e.f. 
    15-9-1964).</pagenote>

<pagenote><number>233</number>   Ins. by Act 68 of 1982, sec. 36 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>234</number>   Subs. by Act 68 of 1982, sec. 37, for certain words (w.e.f. 
    1-2-1983).</pagenote>

<pagenote><number>235</number>   The words “section 32 of” omitted by Act 13 of 1964, sec. 29 (w.e.f. 
    15-9-1964).</pagenote>

<pagenote><number>236</number>   Subs. by Act 68 of 1982, sec. 38, for “the Code of Criminal Procedure, 
    1898 (5 of 1898)” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>237</number>   Subs. by Act 68 of 1982, sec. 38, for “any  Presidency Magistrate or 
    any Magistrate of the first class” (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>238</number> Subs. by Act 11 of 1955, sec. 16, for section 34 (w.e.f. 
15-4-1955).</pagenote>

<pagenote><number>239</number> Ins. by Act 68 of 1982, sec. 39 (w.e.f. 1-2-1983).</pagenote>

<pagenote><number>240</number> Subs. by Act 26 of 2008, sec. 19, for “all offences under 
this Act”.</pagenote>

<pagenote><number>241</number> Ins. by Act 26 of 2008, sec. 20.</pagenote>

<pagenote><number>242</number> Subs. by Act 11 of 1955, sec. 16, for section 34 (w.e.f. 
15-4-1955).</pagenote>

<pagenote><number>243</number> Ins. by Act 26 of 2008, sec. 20.</pagenote>

<pagenote><number>244</number> Subs. by Act 11 of 1955, sec. 16, for section 34 (w.e.f. 
15-4-1955).</pagenote>

<pagenote><number>245</number> Ins. by Act 26 of 2008, sec. 20.</pagenote>

<pagenote><number>246</number> Subs. by Act 11 of 1955, sec. 16, for section 34 (w.e.f. 
15-4-1955).</pagenote>

<pagenote><number>247</number> Ins. by Act 26 of 2008, sec. 20.</pagenote>

<pagenote><number>248</number>   Ins. by Act 13 of 1964, sec. 30 (w.e.f. 15-9-1964).   tc 
    "  
    5. Ins. by Act 13 of 1964, sec. 30 (w.e.f. 15-9-1964)."</pagenote>

<pagenote><number>249</number>   Subs. by Act 68 of 1982, sec. 40, for certain words (w.e.f. 1-2-1983).</pagenote>
</pagefootnote>
</act>